|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q52932605
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241121000229.0 |
|
008
|
|
|
241121nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q52932605
|
|
035
|
|
|
‡a
(OCoLC)Q52932605
|
|
043
|
|
|
‡c
DK
|
|
046
|
|
|
‡f
19521004
|
|
100
|
0 |
|
‡a
Anne Tybjærg-Hansen
‡9
nn
‡9
ast
‡9
nb
‡9
de
‡9
sl
‡9
kl
‡9
is
‡9
fo
|
|
375
|
|
|
‡a
2
‡2
iso5218
|
|
400
|
0 |
|
‡a
Anne Tybjærg-Hansen
‡c
dansk læge og forsker
‡9
da
|
|
400
|
0 |
|
‡a
Anne Tybjærg-Hansen
‡c
médecin danoise
‡9
fr
|
|
400
|
0 |
|
‡a
Anne Tybjærg-Hansen
‡c
Danish physician
‡9
en
|
|
400
|
0 |
|
‡a
Anne Tybjærg-Hansen
‡c
Deens onderzoekster
‡9
nl
|
|
400
|
0 |
|
‡a
Anne Tybjaerg-Hansen
‡c
mjeke daneze
‡9
sq
|
|
400
|
0 |
|
‡a
Anne Tybjærg-Hansen
‡c
araştırmacı
‡9
tr
|
|
400
|
0 |
|
‡a
Anne Tybjærg-Hansen
‡c
forskare
‡9
sv
|
|
400
|
0 |
|
‡a
Anne Tybjærg-Hansen
‡c
dochtúir Danmhargach
‡9
ga
|
|
400
|
0 |
|
‡a
Anne Tybjærg-Hansen
‡c
metgessa danesa
‡9
ca
|
|
400
|
0 |
|
‡a
Anne Tybjærg-Hansen
‡c
médica danesa
‡9
es
|
|
670
|
|
|
‡a
Author's 164Ile allele in the beta2-Adrenergic receptor gene is associated with risk of elevated blood pressure in women. The Copenhagen City Heart Study
|
|
670
|
|
|
‡a
Author's A common allele on chromosome 9 associated with coronary heart disease
|
|
670
|
|
|
‡a
Author's A common variant in CCDC93 protects against myocardial infarction and cardiovascular mortality by regulating endosomal trafficking of low-density lipoprotein receptor
|
|
670
|
|
|
‡a
Author's A new variant with two amino acid substitutions: Hb S-Cameroon [beta6
|
|
670
|
|
|
‡a
Author's A new variant with two amino acid substitutions: Hb S-Cameroon [beta6(A3)Glu-->Val;beta90(F6)Glu-->Lys].
|
|
670
|
|
|
‡a
Author's A population-based study of morbidity and mortality in mannose-binding lectin deficiency
|
|
670
|
|
|
‡a
Author's A systematic review and meta-analysis of 130,000 individuals shows smoking does not modify the association of APOE genotype on risk of coronary heart disease
|
|
670
|
|
|
‡a
Author's ABC transporter genes and risk of type 2 diabetes: a study of 40,000 individuals from the general population
|
|
670
|
|
|
‡a
Author's ABCA7 and risk of dementia and vascular disease in the Danish population
|
|
670
|
|
|
‡a
Author's Abdominal aortic aneurysm is associated with a variant in low-density lipoprotein receptor-related protein 1
|
|
670
|
|
|
‡a
Author's Absolute 10-year risk of dementia by age, sex and genotype: a population-based cohort study
|
|
670
|
|
|
‡a
Author's ADH1B and ADH1C genotype, alcohol consumption and biomarkers of liver function: findings from a Mendelian randomization study in 58,313 European origin Danes
|
|
670
|
|
|
‡a
Author's Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci
|
|
670
|
|
|
‡a
Author's Advances in lipid-lowering therapy through gene-silencing technologies
|
|
670
|
|
|
‡a
Author's Alcohol intake, alcohol dehydrogenase genotypes, and liver damage and disease in the Danish general population.
|
|
670
|
|
|
‡a
Author's Alcoholism and alcohol drinking habits predicted from alcohol dehydrogenase genes
|
|
670
|
|
|
‡a
Author's An application of the patient rule-induction method for evaluating the contribution of the Apolipoprotein E and Lipoprotein Lipase genes to predicting ischemic heart disease
|
|
670
|
|
|
‡a
Author's Angiotensinogen and ACE gene polymorphisms and risk of atrial fibrillation in the general population
|
|
670
|
|
|
‡a
Author's Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: a meta-analysis
|
|
670
|
|
|
‡a
Author's Angiotensinogen single nucleotide polymorphisms, elevated blood pressure, and risk of cardiovascular disease
|
|
670
|
|
|
‡a
Author's APOC3 Loss-of-Function Mutations, Remnant Cholesterol, Low-Density Lipoprotein Cholesterol, and Cardiovascular Risk: Mediation and Meta-Analyses of 137 895 Individuals
|
|
670
|
|
|
‡a
Author's Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14,015 stroke cases and pooled analysis of primary biomarker data from up to 60,883 individuals
|
|
670
|
|
|
‡a
Author's Apolipoprotein M and risk of type 2 diabetes
|
|
670
|
|
|
‡a
Author's Association between chromosome 9p21 variants and the ankle-brachial index identified by a meta-analysis of 21 genome-wide association studies
|
|
670
|
|
|
‡a
Author's Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease
|
|
670
|
|
|
‡a
Author's Association of Low Plasma Transthyretin Concentration With Risk of Heart Failure in the General Population
|
|
670
|
|
|
‡a
Author's Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization Analysis
|
|
670
|
|
|
‡a
Author's Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts
|
|
670
|
|
|
‡a
Author's Asthma and COPD in cystic fibrosis intron-8 5T carriers. A population-based study
|
|
670
|
|
|
‡a
Author's AT1 mutations and risk of atrial fibrillation based on genotypes from 71,000 individuals from the general population
|
|
670
|
|
|
‡a
Author's Autosomal recessive hypercholesterolemia in a kindred of Syrian ancestry
|
|
670
|
|
|
‡a
Author's Bayesian methods for meta-analysis of causal relationships estimated using genetic instrumental variables
|
|
670
|
|
|
‡a
Author's Beta2-Adrenergic Receptor Polymorphism Associated With Reduced Lung Function In Two Large Populations
|
|
670
|
|
|
‡a
Author's Blood-brain barrier transcytosis genes, risk of dementia and stroke: a prospective cohort study of 74,754 individuals
|
|
670
|
|
|
‡a
Author's Blood pressure, risk of ischemic cerebrovascular and ischemic heart disease, and longevity in Alpha (1)-antitrypsin deficiency: the Copenhagen City Heart Study
|
|
670
|
|
|
‡a
Author's Body Mass Index and Risk of Alzheimer Disease: a Mendelian Randomization Study of 399,536 Individuals
|
|
670
|
|
|
‡a
Author's C-reactive protein and all-cause mortality--the Copenhagen City Heart Study
|
|
670
|
|
|
‡a
Author's C reactive protein and chronic obstructive pulmonary disease: a Mendelian randomisation approach
|
|
670
|
|
|
‡a
Author's C-reactive protein and risk of ischaemic vascular and cerebrovascular disease--secondary publication
|
|
670
|
|
|
‡a
Author's C-reactive protein and risk of venous thromboembolism in the general population
|
|
670
|
|
|
‡a
Author's C-Reactive Protein and the Risk of Cancer: A Mendelian Randomization Study
|
|
670
|
|
|
‡a
Author's C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease
|
|
670
|
|
|
‡a
Author's C-reactive protein, genetically elevated levels and risk of ischemic heart and cerebrovascular disease
|
|
670
|
|
|
‡a
Author's C-reactive protein levels and body mass index: elucidating direction of causation through reciprocal Mendelian randomization
|
|
670
|
|
|
‡a
Author's Cascade screening in families with inherited cardiac diseases driven by cardiologists: feasibility and nationwide outcome in long QT syndrome
|
|
670
|
|
|
‡a
Author's Causal Associations in Type 2 Diabetes Development
|
|
670
|
|
|
‡a
Author's Change in Body Mass Index Associated With Lowest Mortality in Denmark, 1976-2013.
|
|
670
|
|
|
‡a
Author's Change in lung function and morbidity from chronic obstructive pulmonary disease in Alpha 1-antitrypsin MZ heterozygotes: A longitudinal study of the general population
|
|
670
|
|
|
‡a
Author's CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls
|
|
670
|
|
|
‡a
Author's Combined analysis of six lipoprotein lipase genetic variants on triglycerides, high-density lipoprotein, and ischemic heart disease: cross-sectional, prospective, and case-control studies from the Copenhagen City Heart Study
|
|
670
|
|
|
‡a
Author's Combined Association of Body Mass Index and Alcohol Consumption With Biomarkers for Liver Injury and Incidence of Liver Disease
|
|
670
|
|
|
‡a
Author's Combined Effect of PNPLA3, TM6SF2, and HSD17B13 Variants on Risk of Cirrhosis and Hepatocellular Carcinoma in the General Population
|
|
670
|
|
|
‡a
Author's Common and rare alleles in apolipoprotein B contribute to plasma levels of low-density lipoprotein cholesterol in the general population
|
|
670
|
|
|
‡a
Author's Common clinical practice versus new PRIM score in predicting coronary heart disease risk
|
|
670
|
|
|
‡a
Author's Common variants in Alzheimer's disease and risk stratification by polygenic risk scores
|
|
670
|
|
|
‡a
Author's Components of the Metabolic Syndrome and Risk of Type 2 Diabetes
|
|
670
|
|
|
‡a
Author's Context-dependent associations between variation in risk of ischemic heart disease and variation in the 5' promoter region of the apolipoprotein E gene in Danish women
|
|
670
|
|
|
‡a
Author's Contribution of regulatory and structural variations in APOE to predicting dyslipidemia
|
|
670
|
|
|
‡a
Author's Copy number variation in glutathione S-transferases M1 and T1 and ischemic vascular disease: four studies and meta-analyses.
|
|
670
|
|
|
‡a
Author's CYP1B1 genotype and risk of cardiovascular disease, pulmonary disease, and cancer in 50,000 individuals
|
|
670
|
|
|
‡a
Author's Data on plasma levels of apolipoprotein E, correlations with lipids and lipoproteins stratified by APOE genotype, and risk of ischemic heart disease
|
|
670
|
|
|
‡a
Author's Does Elevated C-Reactive Protein Increase Atrial Fibrillation Risk?
|
|
670
|
|
|
‡a
Author's Does greater adiposity increase blood pressure and hypertension risk?: Mendelian randomization using the FTO/MC4R genotype
|
|
670
|
|
|
‡a
Author's Effect of APOE ε Genotype on Lipoprotein
|
|
670
|
|
|
‡a
Author's Effect of APOE ε Genotype on Lipoprotein(a) and the Associated Risk of Myocardial Infarction and Aortic Valve Stenosis
|
|
670
|
|
|
‡a
Author's Effect of gender on phenotypic expression of the S447X mutation in LPL: the Copenhagen City Heart Study
|
|
670
|
|
|
‡a
Author's Elevated body mass index as a causal risk factor for symptomatic gallstone disease: a Mendelian randomization study
|
|
670
|
|
|
‡a
Author's Elevated Fibrinogen Levels Are Associated with Risk of Pulmonary Embolism, but Not with Deep Venous Thrombosis
|
|
670
|
|
|
‡a
Author's Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population.
|
|
670
|
|
|
‡a
Author's Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation
|
|
670
|
|
|
‡a
Author's Elevated transferrin saturation and risk of diabetes: three population-based studies
|
|
670
|
|
|
‡a
Author's Epigenetic Regulation of Associates With Myocardial Infarction and Platelet Function
|
|
670
|
|
|
‡a
Author's Estrogen Receptor α Polymorphism and Risk of Cardiovascular Disease, Cancer, and Hip Fracture
|
|
670
|
|
|
‡a
Author's European Lipoprotein Club: report of the 31st ELC Annual Conference, Tutzing, 8-11 September 2008.
|
|
670
|
|
|
‡a
Author's European Lipoprotein Club: Report of the 34th ELC annual conference, Tutzing, 5-8 September 2011.
|
|
670
|
|
|
‡a
Author's European lipoprotein club: report of the 35th ELC annual conference (Tutzing, 10th-13th September 2012).
|
|
670
|
|
|
‡a
Author's Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction
|
|
670
|
|
|
‡a
Author's Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease
|
|
670
|
|
|
‡a
Author's Exome-wide association study of plasma lipids in >300,000 individuals
|
|
670
|
|
|
‡a
Author's Extreme bilirubin levels as a causal risk factor for symptomatic gallstone disease
|
|
670
|
|
|
‡a
Author's Extreme concentrations of endogenous sex hormones, ischemic heart disease, and death in women
|
|
670
|
|
|
‡a
Author's Extreme lipoprotein
|
|
670
|
|
|
‡a
Author's Extreme lipoprotein(a) levels and improved cardiovascular risk prediction
|
|
670
|
|
|
‡a
Author's Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study
|
|
670
|
|
|
‡a
Author's Factor V Leiden and the risk for venous thromboembolism in the adult Danish population
|
|
670
|
|
|
‡a
Author's Factor V leiden homozygosity, dyspnea, and reduced pulmonary function
|
|
670
|
|
|
‡a
Author's Factor V Leiden: relation to fertility?
|
|
670
|
|
|
‡a
Author's Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses
|
|
670
|
|
|
‡a
Author's Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.
|
|
670
|
|
|
‡a
Author's Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society
|
|
670
|
|
|
‡a
Author's Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication
|
|
670
|
|
|
‡a
Author's Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanisms
|
|
670
|
|
|
‡a
Author's Four Susceptibility Loci for Gallstone Disease Identified in a Meta-analysis of Genome-Wide Association Studies
|
|
670
|
|
|
‡a
Author's Functional promoter variant in zinc finger protein 202 predicts severe atherosclerosis and ischemic heart disease
|
|
670
|
|
|
‡a
Author's Gender- and age-specific contributions of additional DNA sequence variation in the 5' regulatory region of the APOE gene to prediction of measures of lipid metabolism
|
|
670
|
|
|
‡a
Author's Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
|
|
670
|
|
|
‡a
Author's Genetic associations with valvular calcification and aortic stenosis
|
|
670
|
|
|
‡a
Author's Genetic determinants of LDL, lipoprotein(a), triglyceride-rich lipoproteins and HDL: concordance and discordance with cardiovascular disease risk
|
|
670
|
|
|
‡a
Author's Genetic determinants of the ankle-brachial index: a meta-analysis of a cardiovascular candidate gene 50K SNP panel in the candidate gene association resource (CARe) consortium
|
|
670
|
|
|
‡a
Author's Genetic evidence that lipoprotein(a) associates with atherosclerotic stenosis rather than venous thrombosis
|
|
670
|
|
|
‡a
Author's Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes.
|
|
670
|
|
|
‡a
Author's Genetic inhibition of CETP, ischemic vascular disease and mortality, and possible adverse effects
|
|
670
|
|
|
‡a
Author's Genetic stabilization of transthyretin, cerebrovascular disease, and life expectancy
|
|
670
|
|
|
‡a
Author's Genetic Variants Associated With Increased Plasma Levels of Triglycerides, via Effects on the Lipoprotein Lipase Pathway, Increase Risk of Acute Pancreatitis
|
|
670
|
|
|
‡a
Author's Genetic variants in CYP7A1 and risk of myocardial infarction and symptomatic gallstone disease
|
|
670
|
|
|
‡a
Author's Genetic variants in SUSD2 are associated with the risk of ischemic heart disease
|
|
670
|
|
|
‡a
Author's Genetic variation at PPP1R3B increases hepatic CT attenuation and interacts with prandial status on plasma glucose
|
|
670
|
|
|
‡a
Author's Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population
|
|
670
|
|
|
‡a
Author's Genetic variation in ABCA1 predicts ischemic heart disease in the general population
|
|
670
|
|
|
‡a
Author's Genetic variation in ABCG1 and risk of myocardial infarction and ischemic heart disease
|
|
670
|
|
|
‡a
Author's Genetic variation in clusterin and risk of dementia and ischemic vascular disease in the general population: cohort studies and meta-analyses of 362,338 individuals.
|
|
670
|
|
|
‡a
Author's Genetic Variation in GSTP1, Lung Function, Risk of Lung Cancer, and Mortality
|
|
670
|
|
|
‡a
Author's Genetic variation in liver X receptor Alpha and risk of ischemic vascular disease in the general population
|
|
670
|
|
|
‡a
Author's Genetic Variation in NPC1L1 and Risk of Gallstone Disease
|
|
670
|
|
|
‡a
Author's Genetic variation in the cholesterol transporter NPC1L1, ischaemic vascular disease, and gallstone disease
|
|
670
|
|
|
‡a
Author's Genetic variation in WRN and ischemic stroke: General population studies and meta-analyses
|
|
670
|
|
|
‡a
Author's Genetic variations in alcohol dehydrogenase, drinking habits and alcoholism
|
|
670
|
|
|
‡a
Author's [Genetically determined reduction in antioxidative protection and increased risk of ischemic heart disease--secondary publication]
|
|
670
|
|
|
‡a
Author's Genetically elevated apolipoprotein A-I, high-density lipoprotein cholesterol levels, and risk of ischemic heart disease
|
|
670
|
|
|
‡a
Author's Genetically elevated C-reactive protein and ischemic vascular disease
|
|
670
|
|
|
‡a
Author's Genetically elevated lipoprotein
|
|
670
|
|
|
‡a
Author's Genetically elevated lipoprotein(a) and increased risk of myocardial infarction
|
|
670
|
|
|
‡a
Author's Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction
|
|
670
|
|
|
‡a
Author's Genetically increased antioxidative protection and decreased chronic obstructive pulmonary disease
|
|
670
|
|
|
‡a
Author's Genetically reduced antioxidative protection and increased ischemic heart disease risk: The Copenhagen City Heart Study.
|
|
670
|
|
|
‡a
Author's Genetically reduced soluble epoxide hydrolase activity and risk of stroke and other cardiovascular disease
|
|
670
|
|
|
‡a
Author's Genetics of Coronary Artery Disease
|
|
670
|
|
|
‡a
Author's Genome-wide association analysis of high-density lipoprotein cholesterol in the population-based KORA study sheds new light on intergenic regions
|
|
670
|
|
|
‡a
Author's GUESS-ing polygenic associations with multiple phenotypes using a GPU-based evolutionary stochastic search algorithm
|
|
670
|
|
|
‡a
Author's HDL Cholesterol and Risk of Type 2 Diabetes: A Mendelian Randomization Study.
|
|
670
|
|
|
‡a
Author's Hemochromatosis genotypes and risk of 31 disease endpoints: meta-analyses including 66,000 cases and 226,000 controls
|
|
670
|
|
|
‡a
Author's Hemochromatosis mutations in the general population: iron overload progression rate
|
|
670
|
|
|
‡a
Author's Hepatic lipase, genetically elevated high-density lipoprotein, and risk of ischemic cardiovascular disease
|
|
670
|
|
|
‡a
Author's Hepatic lipase mutations,elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: the Copenhagen City Heart Study
|
|
670
|
|
|
‡a
Author's Hereditary hemochromatosis and risk of ischemic heart disease: a prospective study and a case-control study
|
|
670
|
|
|
‡a
Author's Heterozygosity for R1141X in ABCC6 and risk of ischemic vascular disease
|
|
670
|
|
|
‡a
Author's High body mass index and cancer risk-a Mendelian randomisation study
|
|
670
|
|
|
‡a
Author's High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study
|
|
670
|
|
|
‡a
Author's High pre-beta1 HDL concentrations and low lecithin: cholesterol acyltransferase activities are strong positive risk markers for ischemic heart disease and independent of HDL-cholesterol
|
|
670
|
|
|
‡a
Author's High Risk of Fatty Liver Disease Amplifies the Alanine Transaminase-Lowering Effect of a HSD17B13 Variant
|
|
670
|
|
|
‡a
Author's High-throughput genotyping of copy number variation in glutathione S-transferases M1 and T1 using real-time PCR in 20,687 individuals
|
|
670
|
|
|
‡a
Author's HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
|
|
670
|
|
|
‡a
Author's HNPCC mutation MLH1 P648S makes the functional protein unstable, and homozygosity predisposes to mild neurofibromatosis type 1.
|
|
670
|
|
|
‡a
Author's [Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society]
|
|
670
|
|
|
‡a
Author's Hyperhomocysteinemia, methylenetetrahydrofolate reductase c.677C>T polymorphism and risk of cancer: cross-sectional and prospective studies and meta-analyses of 75,000 cases and 93,000 controls
|
|
670
|
|
|
‡a
Author's Identification and replication of six new loci associated with gallstone disease
|
|
670
|
|
|
‡a
Author's Impact of cardiovascular risk factors and genetics on 10-year absolute risk of dementia: risk charts for targeted prevention
|
|
670
|
|
|
‡a
Author's Impact of Glucose Level on Micro- and Macrovascular Disease in the General Population: A Mendelian Randomization Study
|
|
670
|
|
|
‡a
Author's Impact of glucose on risk of dementia: Mendelian randomisation studies in 115,875 individuals
|
|
670
|
|
|
‡a
Author's Impact of LDL Cholesterol on Microvascular Versus Macrovascular Disease: A Mendelian Randomization Study
|
|
670
|
|
|
‡a
Author's Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B: the Copenhagen City Heart Study
|
|
670
|
|
|
‡a
Author's Increased Baseline C-Reactive Protein Concentrations Are Associated with Increased Risk of Infections: Results from 2 Large Danish Population Cohorts
|
|
670
|
|
|
‡a
Author's Increased risk of breast cancer associated with CHEK2*1100delC
|
|
670
|
|
|
‡a
Author's Increased risk of ovarian cancer in integrin beta3 Leu33Pro homozygotes
|
|
670
|
|
|
‡a
Author's Influence of Factor V Leiden on susceptibility to and outcome from critical illness: a genetic association study
|
|
670
|
|
|
‡a
Author's Influence of the factor V Leiden mutation on infectious disease susceptibility and outcome: a population-based study
|
|
670
|
|
|
‡a
Author's Inhibition of Cholesteryl Ester Transfer Protein Preserves High-Density Lipoprotein Cholesterol and Improves Survival in Sepsis
|
|
670
|
|
|
‡a
Author's Integrin beta3 Leu33Pro homozygosity and risk of cancer
|
|
670
|
|
|
‡a
Author's Integrin beta3 Leu33Pro polymorphism and risk of hip fracture: 25 years follow-up of 9233 adults from the general population
|
|
670
|
|
|
‡a
Author's Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
|
|
670
|
|
|
‡a
Author's LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals
|
|
670
|
|
|
‡a
Author's Leukotriene C4 synthase and ischemic cardiovascular disease and obstructive pulmonary disease in 13,000 individuals
|
|
670
|
|
|
‡a
Author's Levels of apolipoprotein M are not associated with the risk of coronary heart disease in two independent case-control studies
|
|
670
|
|
|
‡a
Author's Lipoprotein(a) and familial hypercholesterolaemia - Authors' reply.
|
|
670
|
|
|
‡a
Author's Lipoprotein(a) and risk of myocardial infarction--genetic epidemiologic evidence of causality
|
|
670
|
|
|
‡a
Author's Lipoprotein(a) as a cardiovascular risk factor: current status
|
|
670
|
|
|
‡a
Author's Lipoprotein distribution and serum concentrations of 7α-hydroxy-4-cholesten-3-one and bile acids: effects of monogenic disturbances in high-density lipoprotein metabolism
|
|
670
|
|
|
‡a
Author's Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals
|
|
670
|
|
|
‡a
Author's Loss-of-function mutation in ABCA1 and risk of Alzheimer's disease and cerebrovascular disease
|
|
670
|
|
|
‡a
Author's Loss-of-function mutations in APOC3 and risk of ischemic vascular disease
|
|
670
|
|
|
‡a
Author's Low-density lipoprotein cholesterol and risk of gallstone disease: a Mendelian randomization study and meta-analyses
|
|
670
|
|
|
‡a
Author's Low-density lipoprotein cholesterol and the risk of cancer: a mendelian randomization study.
|
|
670
|
|
|
‡a
Author's Low LDL Cholesterol by PCSK9 Variation Reduces Cardiovascular Mortality
|
|
670
|
|
|
‡a
Author's Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer's disease and Parkinson's disease: Mendelian randomisation study
|
|
670
|
|
|
‡a
Author's Low nonfasting triglycerides and reduced all-cause mortality: a mendelian randomization study
|
|
670
|
|
|
‡a
Author's Medullary thyroid cancer: RET testing of an archival material
|
|
670
|
|
|
‡a
Author's Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism: prospective and case-control studies from the Copenhagen City Heart Study
|
|
670
|
|
|
‡a
Author's Missense polymorphisms in BRCA1 and BRCA2 and risk of breast and ovarian cancer.
|
|
670
|
|
|
‡a
Author's Missense Variants in Plakophilin-2 in Arrhythmogenic Right Ventricular Cardiomyopathy Patients – Disease-Causing or Innocent Bystanders?
|
|
670
|
|
|
‡a
Author's Mitochondrial haplogroups: ischemic cardiovascular disease, other diseases, mortality, and longevity in the general population
|
|
670
|
|
|
‡a
Author's Modifications to the Patient Rule-Induction Method that utilize non-additive combinations of genetic and environmental effects to define partitions that predict ischemic heart disease
|
|
670
|
|
|
‡a
Author's Morbidity and mortality in persons with mannose-binding lectin deficiency. The Osterbro study
|
|
670
|
|
|
‡a
Author's Mutation in ABCA1 predicted risk of ischemic heart disease in the Copenhagen City Heart Study Population
|
|
670
|
|
|
‡a
Author's Mutation in apolipoprotein B associated with hypobetalipoproteinemia despite decreased binding to the low density lipoprotein receptor
|
|
670
|
|
|
‡a
Author's Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217
|
|
670
|
|
|
‡a
Author's Mutations in Danish patients with long QT syndrome and the identification of a large founder family with p.F29L in KCNH2.
|
|
670
|
|
|
‡a
Author's Nanogen microelectronic chip for large-scale genotyping.
|
|
670
|
|
|
‡a
Author's Naturally Occurring Variants in LRP1
|
|
670
|
|
|
‡a
Author's Naturally Occurring Variants in LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1) Affect HDL (High-Density Lipoprotein) Metabolism Through ABCA1 (ATP-Binding Cassette A1) and SR-B1 (Scavenger Receptor Class B Type 1) in Humans.
|
|
670
|
|
|
‡a
Author's New insights into the genetic etiology of Alzheimer's disease and related dementias
|
|
670
|
|
|
‡a
Author's Nicotinic acetylcholine receptor polymorphism, smoking behavior, and tobacco-related cancer and lung and cardiovascular diseases: a cohort study
|
|
670
|
|
|
‡a
Author's No association of breast cancer risk with integrin beta3 (ITGB3) Leu33Pro genotype
|
|
670
|
|
|
‡a
Author's Non-fasting triglycerides and risk of for myocardial infarction and death among women and men
|
|
670
|
|
|
‡a
Author's Nonfasting glucose, ischemic heart disease, and myocardial infarction: a Mendelian randomization study
|
|
670
|
|
|
‡a
Author's Nonfasting triglycerides and risk of ischemic stroke in the general population
|
|
670
|
|
|
‡a
Author's [Nonfasting triglycerides and risk of ischemic stroke--secondary publication].
|
|
670
|
|
|
‡a
Author's Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women
|
|
670
|
|
|
‡a
Author's Nonfasting triglycerides, cholesterol, and ischemic stroke in the general population
|
|
670
|
|
|
‡a
Author's Nose and blood pressure
|
|
670
|
|
|
‡a
Author's Novel genes in LDL metabolism--a comprehensive overview
|
|
670
|
|
|
‡a
Author's Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration
|
|
670
|
|
|
‡a
Author's Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
|
|
670
|
|
|
‡a
Author's PCSK9 R46L Loss-of-Function Mutation Reduces Lipoprotein(a), LDL Cholesterol, and Risk of Aortic Valve Stenosis.
|
|
670
|
|
|
‡a
Author's PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses
|
|
670
|
|
|
‡a
Author's Penetrance of NOD2/CARD15 genetic variants in the general population
|
|
670
|
|
|
‡a
Author's Pentanucleotide repeat polymorphism, lipoprotein(a) levels, and risk of ischemic heart disease
|
|
670
|
|
|
‡a
Author's Phenotype of heterozygotes for low-density lipoprotein receptor mutations identified in different background populations
|
|
670
|
|
|
‡a
Author's Plakophilin-2 c.419C>T and risk of heart failure and arrhythmias in the general population
|
|
670
|
|
|
‡a
Author's Plasma apolipoprotein E levels and risk of dementia: A Mendelian randomization study of 106,562 individuals.
|
|
670
|
|
|
‡a
Author's Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.
|
|
670
|
|
|
‡a
Author's Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
|
|
670
|
|
|
‡a
Author's Plasma levels of 27-hydroxycholesterol in humans and mice with monogenic disturbances of high density lipoprotein metabolism
|
|
670
|
|
|
‡a
Author's Plasma levels of apolipoprotein E and risk of dementia in the general population
|
|
670
|
|
|
‡a
Author's Plasma levels of apolipoprotein E and risk of ischemic heart disease in the general population
|
|
670
|
|
|
‡a
Author's Plasma levels of apolipoprotein E, APOE genotype, and all-cause and cause-specific mortality in 105 949 individuals from a white general population cohort
|
|
670
|
|
|
‡a
Author's Plasma YKL-40 and total and disease-specific mortality in the general population
|
|
670
|
|
|
‡a
Author's Platelet glycoprotein IIb/IIIa Pl
|
|
670
|
|
|
‡a
Author's Platelet glycoprotein IIb/IIIa Pl(A2)/Pl(A2) homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men: the Copenhagen City Heart Study
|
|
670
|
|
|
‡a
Author's Polymorphism in APOB associated with increased low-density lipoprotein levels in both genders in the general population
|
|
670
|
|
|
‡a
Author's Polymorphisms in apolipoprotein B and risk of ischemic stroke
|
|
670
|
|
|
‡a
Author's Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL.
|
|
670
|
|
|
‡a
Author's Population-based resequencing of APOA1 in 10,330 individuals: spectrum of genetic variation, phenotype, and comparison with extreme phenotype approach
|
|
670
|
|
|
‡a
Author's Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Main Text
|
|
670
|
|
|
‡a
Author's Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Narrative Review
|
|
670
|
|
|
‡a
Author's Postprandial Hypertriglyceridaemia Revisited in the Era of Non-fasting Lipid Profiles: Executive Summary of a 2019 Expert Panel Statement
|
|
670
|
|
|
‡a
Author's Prevalence of hemochromatosis-associated mutations in the hemochromatosis gene in the Danish population
|
|
670
|
|
|
‡a
Author's Promoter haplotype of a new ABCA1 mutant influences expression of familial hypo Alpha lipoproteinemia
|
|
670
|
|
|
‡a
Author's Promotor polymorphisms in leukotriene C4 synthase and risk of ischemic cerebrovascular disease
|
|
670
|
|
|
‡a
Author's Prothrombin and risk of venous thromboembolism, ischemic heart disease and ischemic cerebrovascular disease in the general population
|
|
670
|
|
|
‡a
Author's Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity.
|
|
670
|
|
|
‡a
Author's Rare and low-frequency coding variants alter human adult height
|
|
670
|
|
|
‡a
Author's Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease
|
|
670
|
|
|
‡a
Author's Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes.
|
|
670
|
|
|
‡a
Author's Relationship between Genetic Variation at PPP1R3B and Liver Glycogen and Triglyceride Levels
|
|
670
|
|
|
‡a
Author's Remnant cholesterol as a causal risk factor for ischemic heart disease
|
|
670
|
|
|
‡a
Author's Remnant cholesterol, low-density lipoprotein cholesterol, and blood pressure as mediators from obesity to ischemic heart disease.
|
|
670
|
|
|
‡a
Author's Reply to Letters Regarding Article, “Elevated Remnant Cholesterol Causes Both Low-Grade Inflammation and Ischemic Heart Disease, Whereas Elevated Low-Density Lipoprotein Cholesterol Causes Ischemic Heart Disease Without Inflammation”
|
|
670
|
|
|
‡a
Author's Report of the 33rd annual conference of the European Lipoprotein Club, Tutzing, 6-9 September 2010.
|
|
670
|
|
|
‡a
Author's Response
|
|
670
|
|
|
‡a
Author's Response to letter regarding article, "visible age-related signs and risk of ischemic heart disease in the general population: a prospective cohort study".
|
|
670
|
|
|
‡a
Author's Response to: liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease
|
|
670
|
|
|
‡a
Author's Response to the Letter: Response to "Use of biomarkers to identify new drug targets and to predict risk of cardiometabolic outcomes" by Abasi A., et al.
|
|
670
|
|
|
‡a
Author's Risk of cancer by ATM missense mutations in the general population.
|
|
670
|
|
|
‡a
Author's Risk of ischemic heart and ischemic cerebrovascular disease is not increased in S, Z, and 11478A Alpha 1-antitrypsin carriers of the Copenhagen City Heart Study
|
|
670
|
|
|
‡a
Author's rs641738C>T near MBOAT7 is associated with liver fat, ALT, and fibrosis in NAFLD: a meta-analysis
|
|
670
|
|
|
‡a
Author's S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease
|
|
670
|
|
|
‡a
Author's SCARB1 Gene Variants Are Associated With the Phenotype of Combined High High-Density Lipoprotein Cholesterol and High Lipoprotein
|
|
670
|
|
|
‡a
Author's SCARB1 Gene Variants Are Associated With the Phenotype of Combined High High-Density Lipoprotein Cholesterol and High Lipoprotein (a).
|
|
670
|
|
|
‡a
Author's Scavenger receptor AI/II truncation, lung function and COPD in 48,700 individuals
|
|
670
|
|
|
‡a
Author's Screening of three novel candidate genes in arrhythmogenic right ventricular cardiomyopathy
|
|
670
|
|
|
‡a
Author's Secretory phospholipase A
|
|
670
|
|
|
‡a
Author's Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study
|
|
670
|
|
|
‡a
Author's Serum Soluble CD163 Predicts Risk of Type 2 Diabetes in the General Population
|
|
670
|
|
|
‡a
Author's Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study
|
|
670
|
|
|
‡a
Author's Sex Hormones and Ischemic Stroke: A Prospective Cohort Study and Meta-Analyses
|
|
670
|
|
|
‡a
Author's Short telomere length, cancer survival, and cancer risk in 47102 individuals
|
|
670
|
|
|
‡a
Author's Short telomere length, myocardial infarction, ischemic heart disease, and early death
|
|
670
|
|
|
‡a
Author's Single nucleotide polymorphism in the low-density lipoprotein receptor is associated with a threefold risk of stroke. A case-control and prospective study
|
|
670
|
|
|
‡a
Author's [Six case-control studies from the Osterbro-study
|
|
670
|
|
|
‡a
Author's [Six case-control studies from the Osterbro-study (The Copenhagen City Heart Study). Angiotensinogen mutations and risk of myocardial and cerebral ischemia]
|
|
670
|
|
|
‡a
Author's Splice site mutations in mismatch repair genes and risk of cancer in the general population.
|
|
670
|
|
|
‡a
Author's Sterol transporter adenosine triphosphate-binding cassette transporter G8, gallstones, and biliary cancer in 62,000 individuals from the general population
|
|
670
|
|
|
‡a
Author's STROBE-MR: Guidelines for strengthening the reporting of Mendelian randomization studies
|
|
670
|
|
|
‡a
Author's Subgroups at high risk for ischaemic heart disease:identification and validation in 67 000 individuals from the general population
|
|
670
|
|
|
‡a
Author's Subsets of SNPs define rare genotype classes that predict ischemic heart disease
|
|
670
|
|
|
‡a
Author's Surfactant Protein-B 121ins2 Heterozygosity, Reduced Pulmonary Function, and Chronic Obstructive Pulmonary Disease in Smokers
|
|
670
|
|
|
‡a
Author's Surfactant Protein-B 121ins2 Heterozygosity, Reduced Pulmonary Function And COPD In Smokers
|
|
670
|
|
|
‡a
Author's Systematically missing confounders in individual participant data meta-analysis of observational cohort studies
|
|
670
|
|
|
‡a
Author's The ABCG5/8 cholesterol transporter and myocardial infarction versus gallstone disease.
|
|
670
|
|
|
‡a
Author's The Dynamic and Multifaceted Nature of Cardiovascular Disease and Using Genetic Testing to Inform Clinical Care: An International Perspective
|
|
670
|
|
|
‡a
Author's The effect of elevated body mass index on ischemic heart disease risk: causal estimates from a Mendelian randomisation approach
|
|
670
|
|
|
‡a
Author's The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases
|
|
670
|
|
|
‡a
Author's The European Heart Journal: leading the fight to reduce the global burden of cardiovascular disease
|
|
670
|
|
|
‡a
Author's [The genome and cardiology]
|
|
670
|
|
|
‡a
Author's The influence of genotype on vascular endothelial growth factor and regulation of myocardial collateral blood flow in patients with acute and chronic coronary heart disease
|
|
670
|
|
|
‡a
Author's The methylenetetrahydrofolate reductase C677T genotype and the risk of obesity in three large population-based cohorts
|
|
670
|
|
|
‡a
Author's The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of apoB-containing particles.
|
|
670
|
|
|
‡a
Author's The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
|
|
670
|
|
|
‡a
Author's The selective peroxisome proliferator-activated receptor Alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction
|
|
670
|
|
|
‡a
Author's The Sialylation Pathway and Coronary Artery Disease
|
|
670
|
|
|
‡a
Author's Total and cause-specific mortality by elevated transferrin saturation and hemochromatosis genotype in individuals with diabetes: two general population studies
|
|
670
|
|
|
‡a
Author's Total and cause-specific mortality by moderately and markedly increased ferritin concentrations: general population study and metaanalysis
|
|
670
|
|
|
‡a
Author's Total mortality by elevated transferrin saturation in patients with diabetes
|
|
670
|
|
|
‡a
Author's Total mortality by transferrin saturation levels: two general population studies and a metaanalysis
|
|
670
|
|
|
‡a
Author's TRIB1 and GCKR polymorphisms, lipid levels, and risk of ischemic heart disease in the general population.
|
|
670
|
|
|
‡a
Author's Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
|
|
670
|
|
|
‡a
Author's Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
|
|
670
|
|
|
‡a
Author's Triglycerides as a Shared Risk Factor between Dementia and Atherosclerotic Cardiovascular Disease: A Study of 125 727 Individuals
|
|
670
|
|
|
‡a
Author's Tumor suppressor p53 Arg72Pro polymorphism and longevity, cancer survival, and risk of cancer in the general population
|
|
670
|
|
|
‡a
Author's Two novel mutations in surfactant protein-C, lung function and obstructive lung disease
|
|
670
|
|
|
‡a
Author's U-shaped relationship of HDL and risk of infectious disease: two prospective population-based cohort studies
|
|
670
|
|
|
‡a
Author's Use of allele-specific FAIRE to determine functional regulatory polymorphism using large-scale genotyping arrays
|
|
670
|
|
|
‡a
Author's Using genetic loci to understand the relationship between adiposity and psychological distress: a Mendelian Randomization study in the Copenhagen General Population Study of 53 221 adults
|
|
670
|
|
|
‡a
Author's Using genetics to explore whether the cholesterol-lowering drug ezetimibe may cause an increased risk of cancer
|
|
670
|
|
|
‡a
Author's Using human genetics to predict the effects and side-effects of drugs
|
|
670
|
|
|
‡a
Author's Using Human Genetics to Predict the Effects and Side Effects of Lipoprotein(a) Lowering Drugs
|
|
670
|
|
|
‡a
Author's Validated context-dependent associations of coronary heart disease risk with genotype variation in the chromosome 9p21 region: the Atherosclerosis Risk in Communities study
|
|
670
|
|
|
‡a
Author's Visible age-related signs and risk of ischemic heart disease in the general population: a prospective cohort study.
|
|
670
|
|
|
‡a
Author's Visible aging signs as risk markers for ischemic heart disease: Epidemiology, pathogenesis and clinical implications
|
|
670
|
|
|
‡a
Author's Whole-Genome Sequencing Coupled to Imputation Discovers Genetic Signals for Anthropometric Traits
|
|
670
|
|
|
‡a
Author's Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study
|
|
670
|
|
|
‡a
Author's YKL-40 levels and atrial fibrillation in the general population
|
|
670
|
|
|
‡a
Author's Zinc Finger Protein 202: a new candidate gene for ischemic heart disease: The Copenhagen City Heart Study
|
|
670
|
|
|
‡a
Author's Zinc Finger Protein 202, genetic variation, and HDL cholesterol in the general population
|
|
670
|
|
|
‡a
Author's β2-adrenergic receptor polymorphisms, asthma and COPD: two large population-based studies
|
|
670
|
|
|
‡a
Author's β2-Adrenergic Receptor Thr164Ile Polymorphism, Obesity, and Diabetes: Comparison with FTO, MC4R, and TMEM18 Polymorphisms in More Than 64,000 Individuals
|
|
670
|
|
|
‡a
Author's δF508 heterozygosity and asthma
|
|
670
|
|
|
‡a
Author's প্রত্যুত্তর
|
|
670
|
|
|
‡a
wikidata site links
‡u
https://da.wikipedia.org/wiki/Anne_Tybjærg-Hansen
|
|
912
|
|
|
‡a
associationbetweenchromosome9p21variantsandtheanklebrachialindexidentifiedbyametaanalysisof21genomewideassociationstudies
‡A
Association between chromosome 9p21 variants and the ankle-brachial index identified by a meta-analysis of 21 genome-wide association studies
‡9
1
|
|
912
|
|
|
‡a
commonvariantsinalzheimersdiseaseandriskstratificationbypolygenicriskscores
‡A
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores
‡9
1
|
|
912
|
|
|
‡a
পরতযততর
‡A
প্রত্যুত্তর
‡9
1
|
|
912
|
|
|
‡a
wholegenomesequencingcoupledtoimputationdiscoversgeneticsignalsforanthropometrictraits
‡A
Whole-Genome Sequencing Coupled to Imputation Discovers Genetic Signals for Anthropometric Traits
‡9
1
|
|
912
|
|
|
‡a
emergingriskfactorscollaborationanalysisofindividualdataonlipidinflammatoryandothermarkersinover11millionparticipantsin104prospectivestudiesofcardiovasculardiseases
‡A
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases
‡9
1
|
|
912
|
|
|
‡a
7prostatecancersusceptibilitylociidentifiedbyamultistagegenomewideassociationstudy
‡A
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study
‡9
1
|
|
912
|
|
|
‡a
secretoryphospholipasea2iiaandcardiovasculardiseaseamendelianrandomizationstudy
‡A
Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study
‡9
1
|
|
912
|
|
|
‡a
secretoryphospholipasea
‡A
Secretory phospholipase A
‡9
1
|
|
912
|
|
|
‡a
response
‡A
Response
‡9
1
|
|
912
|
|
|
‡a
refiningtheaccuracyofvalidatedtargetidentificationthroughcodingvariantfinemappingintype2diabetes
‡A
Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes.
‡9
1
|
|
912
|
|
|
‡a
rareandlowfrequencycodingvariantsalterhumanadultheight
‡A
Rare and low-frequency coding variants alter human adult height
‡9
1
|
|
912
|
|
|
‡a
publishercorrectionproteinalteringvariantsassociatedwithbodymassindeximplicatepathwaysthatcontrolenergyintakeandexpenditureinobesity
‡A
Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity.
‡9
1
|
|
912
|
|
|
‡a
exomesequencingidentifiesrareldlrandapoa5allelesconferringriskformyocardialinfarction
‡A
Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction
‡9
1
|
|
912
|
|
|
‡a
exomewideassociationstudyofplasmalipidsin300000individuals
‡A
Exome-wide association study of plasma lipids in >300,000 individuals
‡9
1
|
|
912
|
|
|
‡a
plasmahdlcholesterolandriskofmyocardialinfarctionamendelianrandomisationstudy
‡A
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
‡9
1
|
|
912
|
|
|
‡a
newinsightsintothegeneticetiologyofalzheimersdiseaseandrelateddementias
‡A
New insights into the genetic etiology of Alzheimer's disease and related dementias
‡9
1
|
|
912
|
|
|
‡a
interleukin6receptorpathwaysincoronaryheartdiseaseacollaborativemetaanalysisof82studies
‡A
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
‡9
1
|
|
919
|
|
|
‡a
factor5leidenthecopenhagencityheartstudyand2metaanalyses
‡A
Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses
‡9
1
|
|
919
|
|
|
‡a
factor5leidenhomozygositydyspneaandreducedpulmonaryfunction
‡A
Factor V leiden homozygosity, dyspnea, and reduced pulmonary function
‡9
1
|
|
919
|
|
|
‡a
factor5leidenandtheriskforvenousthromboembolismintheadultdanishpopulation
‡A
Factor V Leiden and the risk for venous thromboembolism in the adult Danish population
‡9
1
|
|
919
|
|
|
‡a
164ilealleleinthebeta2adrenergicreceptorgeneisassociatedwithriskofelevatedbloodpressureinwomenthecopenhagencityheartstudy
‡A
164Ile allele in the beta2-Adrenergic receptor gene is associated with risk of elevated blood pressure in women. The Copenhagen City Heart Study
‡9
1
|
|
919
|
|
|
‡a
commonalleleonchromosome9associatedwithcoronaryheartdisease
‡A
A common allele on chromosome 9 associated with coronary heart disease
‡9
1
|
|
919
|
|
|
‡a
commonvariantinccdc93protectsagainstmyocardialinfarctionandcardiovascularmortalitybyregulatingendosomaltraffickingoflowdensitylipoproteinreceptor
‡A
A common variant in CCDC93 protects against myocardial infarction and cardiovascular mortality by regulating endosomal trafficking of low-density lipoprotein receptor
‡9
1
|
|
919
|
|
|
‡a
newvariantwith2aminoacidsubstitutionshbscameroonbeta6
‡A
A new variant with two amino acid substitutions: Hb S-Cameroon [beta6
‡9
1
|
|
919
|
|
|
‡a
newvariantwith2aminoacidsubstitutionshbscameroon
‡A
A new variant with two amino acid substitutions: Hb S-Cameroon [beta6(A3)Glu-->Val;beta90(F6)Glu-->Lys].
‡9
1
|
|
919
|
|
|
‡a
populationbasedstudyofmorbidityandmortalityinmannosebindinglectindeficiency
‡A
A population-based study of morbidity and mortality in mannose-binding lectin deficiency
‡9
1
|
|
919
|
|
|
‡a
systematicreviewandmetaanalysisof130000individualsshowssmokingdoesnotmodifytheassociationofapoegenotypeonriskofcoronaryheartdisease
‡A
A systematic review and meta-analysis of 130,000 individuals shows smoking does not modify the association of APOE genotype on risk of coronary heart disease
‡9
1
|
|
919
|
|
|
‡a
abctransportergenesandriskoftype2diabetesastudyof40000individualsfromthegeneralpopulation
‡A
ABC transporter genes and risk of type 2 diabetes: a study of 40,000 individuals from the general population
‡9
1
|
|
919
|
|
|
‡a
abca7andriskofdementiaandvasculardiseaseinthedanishpopulation
‡A
ABCA7 and risk of dementia and vascular disease in the Danish population
‡9
1
|
|
919
|
|
|
‡a
abdominalaorticaneurysmisassociatedwithavariantinlowdensitylipoproteinreceptorrelatedprotein1
‡A
Abdominal aortic aneurysm is associated with a variant in low-density lipoprotein receptor-related protein 1
‡9
1
|
|
919
|
|
|
‡a
absolute10yearriskofdementiabyagesexandgenotypeapopulationbasedcohortstudy
‡A
Absolute 10-year risk of dementia by age, sex and genotype: a population-based cohort study
‡9
1
|
|
919
|
|
|
‡a
adh1bandadh1cgenotypealcoholconsumptionandbiomarkersofliverfunctionfindingsfromamendelianrandomizationstudyin58313europeanorigindanes
‡A
ADH1B and ADH1C genotype, alcohol consumption and biomarkers of liver function: findings from a Mendelian randomization study in 58,313 European origin Danes
‡9
1
|
|
919
|
|
|
‡a
adiposityamplifiesthegeneticriskoffattyliverdiseaseconferredbymultipleloci
‡A
Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci
‡9
1
|
|
919
|
|
|
‡a
advancesinlipidloweringtherapythroughgenesilencingtechnologies
‡A
Advances in lipid-lowering therapy through gene-silencing technologies
‡9
1
|
|
919
|
|
|
‡a
alcoholintakealcoholdehydrogenasegenotypesandliverdamageanddiseaseinthedanishgeneralpopulation
‡A
Alcohol intake, alcohol dehydrogenase genotypes, and liver damage and disease in the Danish general population.
‡9
1
|
|
919
|
|
|
‡a
alcoholismandalcoholdrinkinghabitspredictedfromalcoholdehydrogenasegenes
‡A
Alcoholism and alcohol drinking habits predicted from alcohol dehydrogenase genes
‡9
1
|
|
919
|
|
|
‡a
applicationofthepatientruleinductionmethodforevaluatingthecontributionoftheapolipoproteineandlipoproteinlipasegenestopredictingischemicheartdisease
‡A
An application of the patient rule-induction method for evaluating the contribution of the Apolipoprotein E and Lipoprotein Lipase genes to predicting ischemic heart disease
‡9
1
|
|
919
|
|
|
‡a
angiotensinogenandacegenepolymorphismsandriskofatrialfibrillationinthegeneralpopulation
‡A
Angiotensinogen and ACE gene polymorphisms and risk of atrial fibrillation in the general population
‡9
1
|
|
919
|
|
|
‡a
angiotensinogengenepolymorphismplasmaangiotensinogenandriskofhypertensionandischemicheartdiseaseametaanalysis
‡A
Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: a meta-analysis
‡9
1
|
|
919
|
|
|
‡a
angiotensinogensinglenucleotidepolymorphismselevatedbloodpressureandriskofcardiovasculardisease
‡A
Angiotensinogen single nucleotide polymorphisms, elevated blood pressure, and risk of cardiovascular disease
‡9
1
|
|
919
|
|
|
‡a
apoc3lossoffunctionmutationsremnantcholesterollowdensitylipoproteincholesterolandcardiovascularriskmediationandmetaanalysesof137895individuals
‡A
APOC3 Loss-of-Function Mutations, Remnant Cholesterol, Low-Density Lipoprotein Cholesterol, and Cardiovascular Risk: Mediation and Meta-Analyses of 137 895 Individuals
‡9
1
|
|
919
|
|
|
‡a
apolipoproteinegenotypecardiovascularbiomarkersandriskofstrokesystematicreviewandmetaanalysisof14015strokecasesandpooledanalysisofprimarybiomarkerdatafromupto60883individuals
‡A
Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14,015 stroke cases and pooled analysis of primary biomarker data from up to 60,883 individuals
‡9
1
|
|
919
|
|
|
‡a
apolipoprotein1000andriskoftype2diabetes
‡A
Apolipoprotein M and risk of type 2 diabetes
‡9
1
|
|
919
|
|
|
‡a
associationoflossoffunctionmutationsintheabca1genewithhighdensitylipoproteincholesterollevelsandriskofischemicheartdisease
‡A
Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease
‡9
1
|
|
919
|
|
|
‡a
associationoflowplasmatransthyretinconcentrationwithriskofheartfailureinthegeneralpopulation
‡A
Association of Low Plasma Transthyretin Concentration With Risk of Heart Failure in the General Population
‡9
1
|
|
919
|
|
|
‡a
associationoflpavariantswithriskofcoronarydiseaseandtheimplicationsforlipoproteinaloweringtherapiesamendelianrandomizationanalysis
‡A
Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization Analysis
‡9
1
|
|
919
|
|
|
‡a
associationofplasmauricacidwithischaemicheartdiseaseandbloodpressuremendelianrandomisationanalysisof2largecohorts
‡A
Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts
‡9
1
|
|
919
|
|
|
‡a
asthmaandcopdincysticfibrosisintron85tcarriersapopulationbasedstudy
‡A
Asthma and COPD in cystic fibrosis intron-8 5T carriers. A population-based study
‡9
1
|
|
919
|
|
|
‡a
at1mutationsandriskofatrialfibrillationbasedongenotypesfrom71000individualsfromthegeneralpopulation
‡A
AT1 mutations and risk of atrial fibrillation based on genotypes from 71,000 individuals from the general population
‡9
1
|
|
919
|
|
|
‡a
autosomalrecessivehypercholesterolemiainakindredofsyrianancestry
‡A
Autosomal recessive hypercholesterolemia in a kindred of Syrian ancestry
‡9
1
|
|
919
|
|
|
‡a
bayesianmethodsformetaanalysisofcausalrelationshipsestimatedusinggeneticinstrumentalvariables
‡A
Bayesian methods for meta-analysis of causal relationships estimated using genetic instrumental variables
‡9
1
|
|
919
|
|
|
‡a
beta2adrenergicreceptorpolymorphismassociatedwithreducedlungfunctionin2largepopulations
‡A
Beta2-Adrenergic Receptor Polymorphism Associated With Reduced Lung Function In Two Large Populations
‡9
1
|
|
919
|
|
|
‡a
bloodbrainbarriertranscytosisgenesriskofdementiaandstrokeaprospectivecohortstudyof74754individuals
‡A
Blood-brain barrier transcytosis genes, risk of dementia and stroke: a prospective cohort study of 74,754 individuals
‡9
1
|
|
919
|
|
|
‡a
bloodpressureriskofischemiccerebrovascularandischemicheartdiseaseandlongevityin Alpha 1antitrypsindeficiencythecopenhagencityheartstudy
‡A
Blood pressure, risk of ischemic cerebrovascular and ischemic heart disease, and longevity in Alpha (1)-antitrypsin deficiency: the Copenhagen City Heart Study
‡9
1
|
|
919
|
|
|
‡a
bodymassindexandriskofalzheimerdiseaseamendelianrandomizationstudyof399536individuals
‡A
Body Mass Index and Risk of Alzheimer Disease: a Mendelian Randomization Study of 399,536 Individuals
‡9
1
|
|
919
|
|
|
‡a
100reactiveproteinandallcausemortalitythecopenhagencityheartstudy
‡A
C-reactive protein and all-cause mortality--the Copenhagen City Heart Study
‡9
1
|
|
919
|
|
|
‡a
100reactiveproteinandchronicobstructivepulmonarydiseaseamendelianrandomisationapproach
‡A
C reactive protein and chronic obstructive pulmonary disease: a Mendelian randomisation approach
‡9
1
|
|
919
|
|
|
‡a
100reactiveproteinandriskofischaemicvascularandcerebrovasculardiseasesecondarypublication
‡A
C-reactive protein and risk of ischaemic vascular and cerebrovascular disease--secondary publication
‡9
1
|
|
919
|
|
|
‡a
100reactiveproteinandriskofvenousthromboembolisminthegeneralpopulation
‡A
C-reactive protein and risk of venous thromboembolism in the general population
‡9
1
|
|
919
|
|
|
‡a
100reactiveproteinandtheriskofcanceramendelianrandomizationstudy
‡A
C-Reactive Protein and the Risk of Cancer: A Mendelian Randomization Study
‡9
1
|
|
919
|
|
|
‡a
100reactiveproteinasapredictorofprognosisinchronicobstructivepulmonarydisease
‡A
C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease
‡9
1
|
|
919
|
|
|
‡a
100reactiveproteingeneticallyelevatedlevelsandriskofischemicheartandcerebrovasculardisease
‡A
C-reactive protein, genetically elevated levels and risk of ischemic heart and cerebrovascular disease
‡9
1
|
|
919
|
|
|
‡a
100reactiveproteinlevelsandbodymassindexelucidatingdirectionofcausationthroughreciprocalmendelianrandomization
‡A
C-reactive protein levels and body mass index: elucidating direction of causation through reciprocal Mendelian randomization
‡9
1
|
|
919
|
|
|
‡a
cascadescreeninginfamilieswithinheritedcardiacdiseasesdrivenbycardiologistsfeasibilityandnationwideoutcomeinlongqtsyndrome
‡A
Cascade screening in families with inherited cardiac diseases driven by cardiologists: feasibility and nationwide outcome in long QT syndrome
‡9
1
|
|
919
|
|
|
‡a
causalassociationsintype2diabetesdevelopment
‡A
Causal Associations in Type 2 Diabetes Development
‡9
1
|
|
919
|
|
|
‡a
changeinbodymassindexassociatedwithlowestmortalityindenmark1976
‡A
Change in Body Mass Index Associated With Lowest Mortality in Denmark, 1976-2013.
‡9
1
|
|
919
|
|
|
‡a
changeinlungfunctionandmorbidityfromchronicobstructivepulmonarydiseasein Alpha 1antitrypsinmzheterozygotesalongitudinalstudyofthegeneralpopulation
‡A
Change in lung function and morbidity from chronic obstructive pulmonary disease in Alpha 1-antitrypsin MZ heterozygotes: A longitudinal study of the general population
‡9
1
|
|
919
|
|
|
‡a
chek21100delcgenotypingforclinicalassessmentofbreastcancerriskmetaanalysesof26000patientcasesand27000controls
‡A
CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls
‡9
1
|
|
919
|
|
|
‡a
combinedanalysisof6lipoproteinlipasegeneticvariantsontriglycerideshighdensitylipoproteinandischemicheartdiseasecrosssectionalprospectiveandcasecontrolstudiesfromthecopenhagencityheartstudy
‡A
Combined analysis of six lipoprotein lipase genetic variants on triglycerides, high-density lipoprotein, and ischemic heart disease: cross-sectional, prospective, and case-control studies from the Copenhagen City Heart Study
‡9
1
|
|
919
|
|
|
‡a
combinedassociationofbodymassindexandalcoholconsumptionwithbiomarkersforliverinjuryandincidenceofliverdisease
‡A
Combined Association of Body Mass Index and Alcohol Consumption With Biomarkers for Liver Injury and Incidence of Liver Disease
‡9
1
|
|
919
|
|
|
‡a
combinedeffectofpnpla3tm6sf2andhsd17b13variantsonriskofcirrhosisandhepatocellularcarcinomainthegeneralpopulation
‡A
Combined Effect of PNPLA3, TM6SF2, and HSD17B13 Variants on Risk of Cirrhosis and Hepatocellular Carcinoma in the General Population
‡9
1
|
|
919
|
|
|
‡a
commonandrareallelesinapolipoproteinbcontributetoplasmalevelsoflowdensitylipoproteincholesterolinthegeneralpopulation
‡A
Common and rare alleles in apolipoprotein B contribute to plasma levels of low-density lipoprotein cholesterol in the general population
‡9
1
|
|
919
|
|
|
‡a
factor5leidenrelationtofertility
‡A
Factor V Leiden: relation to fertility?
‡9
1
|
|
919
|
|
|
‡a
commonclinicalpracticeversusnewprimscoreinpredictingcoronaryheartdiseaserisk
‡A
Common clinical practice versus new PRIM score in predicting coronary heart disease risk
‡9
1
|
|
919
|
|
|
‡a
componentsofthemetabolicsyndromeandriskoftype2diabetes
‡A
Components of the Metabolic Syndrome and Risk of Type 2 Diabetes
‡9
1
|
|
919
|
|
|
‡a
contextdependentassociationsbetweenvariationinriskofischemicheartdiseaseandvariationinthe5promoterregionoftheapolipoproteinegeneindanishwomen
‡A
Context-dependent associations between variation in risk of ischemic heart disease and variation in the 5' promoter region of the apolipoprotein E gene in Danish women
‡9
1
|
|
919
|
|
|
‡a
contributionofregulatoryandstructuralvariationsinapoetopredictingdyslipidemia
‡A
Contribution of regulatory and structural variations in APOE to predicting dyslipidemia
‡9
1
|
|
919
|
|
|
‡a
copynumbervariationinglutathionestransferasesm1andt1andischemicvasculardisease4studiesandmetaanalyses
‡A
Copy number variation in glutathione S-transferases M1 and T1 and ischemic vascular disease: four studies and meta-analyses.
‡9
1
|
|
919
|
|
|
‡a
cyp1b1genotypeandriskofcardiovasculardiseasepulmonarydiseaseandcancerin50000individuals
‡A
CYP1B1 genotype and risk of cardiovascular disease, pulmonary disease, and cancer in 50,000 individuals
‡9
1
|
|
919
|
|
|
‡a
dataonplasmalevelsofapolipoproteinecorrelationswithlipidsandlipoproteinsstratifiedbyapoegenotypeandriskofischemicheartdisease
‡A
Data on plasma levels of apolipoprotein E, correlations with lipids and lipoproteins stratified by APOE genotype, and risk of ischemic heart disease
‡9
1
|
|
919
|
|
|
‡a
doeselevated100reactiveproteinincreaseatrialfibrillationrisk
‡A
Does Elevated C-Reactive Protein Increase Atrial Fibrillation Risk?
‡9
1
|
|
919
|
|
|
‡a
doesgreateradiposityincreasebloodpressureandhypertensionriskmendelianrandomizationusingtheftomc4rgenotype
‡A
Does greater adiposity increase blood pressure and hypertension risk?: Mendelian randomization using the FTO/MC4R genotype
‡9
1
|
|
919
|
|
|
‡a
δf508heterozygosityandasthma
‡A
δF508 heterozygosity and asthma
‡9
1
|
|
919
|
|
|
‡a
β2adrenergicreceptorthr164ilepolymorphismobesityanddiabetescomparisonwithftomc4randtmem18polymorphismsinmorethan64000individuals
‡A
β2-Adrenergic Receptor Thr164Ile Polymorphism, Obesity, and Diabetes: Comparison with FTO, MC4R, and TMEM18 Polymorphisms in More Than 64,000 Individuals
‡9
1
|
|
919
|
|
|
‡a
β2adrenergicreceptorpolymorphismsasthmaandcopd2largepopulationbasedstudies
‡A
β2-adrenergic receptor polymorphisms, asthma and COPD: two large population-based studies
‡9
1
|
|
919
|
|
|
‡a
zincfingerprotein202geneticvariationandhdlcholesterolinthegeneralpopulation
‡A
Zinc Finger Protein 202, genetic variation, and HDL cholesterol in the general population
‡9
1
|
|
919
|
|
|
‡a
zincfingerprotein202anewcandidategeneforischemicheartdiseasethecopenhagencityheartstudy
‡A
Zinc Finger Protein 202: a new candidate gene for ischemic heart disease: The Copenhagen City Heart Study
‡9
1
|
|
919
|
|
|
‡a
ykl40levelsandatrialfibrillationinthegeneralpopulation
‡A
YKL-40 levels and atrial fibrillation in the general population
‡9
1
|
|
919
|
|
|
‡a
xanthelasmataarcuscorneaeandischaemicvasculardiseaseanddeathingeneralpopulationprospectivecohortstudy
‡A
Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study
‡9
1
|
|
919
|
|
|
‡a
visibleagingsignsasriskmarkersforischemicheartdiseaseepidemiologypathogenesisandclinicalimplications
‡A
Visible aging signs as risk markers for ischemic heart disease: Epidemiology, pathogenesis and clinical implications
‡9
1
|
|
919
|
|
|
‡a
visibleagerelatedsignsandriskofischemicheartdiseaseinthegeneralpopulationaprospectivecohortstudy
‡A
Visible age-related signs and risk of ischemic heart disease in the general population: a prospective cohort study.
‡9
1
|
|
919
|
|
|
‡a
validatedcontextdependentassociationsofcoronaryheartdiseaseriskwithgenotypevariationinthechromosome9p21regiontheatherosclerosisriskincommunitiesstudy
‡A
Validated context-dependent associations of coronary heart disease risk with genotype variation in the chromosome 9p21 region: the Atherosclerosis Risk in Communities study
‡9
1
|
|
919
|
|
|
‡a
usinghumangeneticstopredicttheeffectsandsideeffectsoflipoproteinaloweringdrugs
‡A
Using Human Genetics to Predict the Effects and Side Effects of Lipoprotein(a) Lowering Drugs
‡9
1
|
|
919
|
|
|
‡a
usinghumangeneticstopredicttheeffectsandsideeffectsofdrugs
‡A
Using human genetics to predict the effects and side-effects of drugs
‡9
1
|
|
919
|
|
|
‡a
usinggeneticstoexplorewhetherthecholesterolloweringdrugezetimibemaycauseanincreasedriskofcancer
‡A
Using genetics to explore whether the cholesterol-lowering drug ezetimibe may cause an increased risk of cancer
‡9
1
|
|
919
|
|
|
‡a
usinggeneticlocitounderstandtherelationshipbetweenadiposityandpsychologicaldistressamendelianrandomizationstudyinthecopenhagengeneralpopulationstudyof53221adults
‡A
Using genetic loci to understand the relationship between adiposity and psychological distress: a Mendelian Randomization study in the Copenhagen General Population Study of 53 221 adults
‡9
1
|
|
919
|
|
|
‡a
useofallelespecificfairetodeterminefunctionalregulatorypolymorphismusinglargescalegenotypingarrays
‡A
Use of allele-specific FAIRE to determine functional regulatory polymorphism using large-scale genotyping arrays
‡9
1
|
|
919
|
|
|
‡a
ushapedrelationshipofhdlandriskofinfectiousdisease2prospectivepopulationbasedcohortstudies
‡A
U-shaped relationship of HDL and risk of infectious disease: two prospective population-based cohort studies
‡9
1
|
|
919
|
|
|
‡a
2novelmutationsinsurfactantprotein100lungfunctionandobstructivelungdisease
‡A
Two novel mutations in surfactant protein-C, lung function and obstructive lung disease
‡9
1
|
|
919
|
|
|
‡a
tumorsuppressorp53arg72propolymorphismandlongevitycancersurvivalandriskofcancerinthegeneralpopulation
‡A
Tumor suppressor p53 Arg72Pro polymorphism and longevity, cancer survival, and risk of cancer in the general population
‡9
1
|
|
919
|
|
|
‡a
triglyceridesasasharedriskfactorbetweendementiaandatheroscleroticcardiovasculardiseaseastudyof125727individuals
‡A
Triglycerides as a Shared Risk Factor between Dementia and Atherosclerotic Cardiovascular Disease: A Study of 125 727 Individuals
‡9
1
|
|
919
|
|
|
‡a
triglyceriderichlipoproteinsandtheirremnantsmetabolicinsightsroleinatheroscleroticcardiovasculardiseaseandemergingtherapeuticstrategiesaconsensusstatementfromtheeuropeanatherosclerosissociety
‡A
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
‡9
1
|
|
919
|
|
|
‡a
triglyceriderichlipoproteinsandhighdensitylipoproteincholesterolinpatientsathighriskofcardiovasculardiseaseevidenceandguidanceformanagement
‡A
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
‡9
1
|
|
919
|
|
|
‡a
trib1andgckrpolymorphismslipidlevelsandriskofischemicheartdiseaseinthegeneralpopulation
‡A
TRIB1 and GCKR polymorphisms, lipid levels, and risk of ischemic heart disease in the general population.
‡9
1
|
|
919
|
|
|
‡a
totalmortalitybytransferrinsaturationlevels2generalpopulationstudiesandametaanalysis
‡A
Total mortality by transferrin saturation levels: two general population studies and a metaanalysis
‡9
1
|
|
919
|
|
|
‡a
totalmortalitybyelevatedtransferrinsaturationinpatientswithdiabetes
‡A
Total mortality by elevated transferrin saturation in patients with diabetes
‡9
1
|
|
919
|
|
|
‡a
totalandcausespecificmortalitybymoderatelyandmarkedlyincreasedferritinconcentrationsgeneralpopulationstudyandmetaanalysis
‡A
Total and cause-specific mortality by moderately and markedly increased ferritin concentrations: general population study and metaanalysis
‡9
1
|
|
919
|
|
|
‡a
totalandcausespecificmortalitybyelevatedtransferrinsaturationandhemochromatosisgenotypeinindividualswithdiabetes2generalpopulationstudies
‡A
Total and cause-specific mortality by elevated transferrin saturation and hemochromatosis genotype in individuals with diabetes: two general population studies
‡9
1
|
|
919
|
|
|
‡a
sialylationpathwayandcoronaryarterydisease
‡A
The Sialylation Pathway and Coronary Artery Disease
‡9
1
|
|
919
|
|
|
‡a
selectiveperoxisomeproliferatoractivatedreceptor Alpha modulatorspparmαparadigmconceptualframeworkandtherapeuticpotentialaconsensusstatementfromtheinternationalatherosclerosissocietyiasandtheresidualriskreduction
‡A
The selective peroxisome proliferator-activated receptor Alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction
‡9
1
|
|
919
|
|
|
‡a
polygenicnatureofhypertriglyceridaemiaimplicationsfordefinitiondiagnosisandmanagement
‡A
The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
‡9
1
|
|
919
|
|
|
‡a
plasmaconcentrationofhdlassociatedapomisinfluencedbyldlreceptormediatedclearanceofapobcontainingparticles
‡A
The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of apoB-containing particles.
‡9
1
|
|
919
|
|
|
‡a
methylenetetrahydrofolatereductasec677tgenotypeandtheriskofobesityin3largepopulationbasedcohorts
‡A
The methylenetetrahydrofolate reductase C677T genotype and the risk of obesity in three large population-based cohorts
‡9
1
|
|
919
|
|
|
‡a
influenceofgenotypeonvascularendothelialgrowthfactorandregulationofmyocardialcollateralbloodflowinpatientswithacuteandchroniccoronaryheartdisease
‡A
The influence of genotype on vascular endothelial growth factor and regulation of myocardial collateral blood flow in patients with acute and chronic coronary heart disease
‡9
1
|
|
919
|
|
|
‡a
genomeandcardiology
‡A
[The genome and cardiology]
‡9
1
|
|
919
|
|
|
‡a
europeanheartjournalleadingthefighttoreducetheglobalburdenofcardiovasculardisease
‡A
The European Heart Journal: leading the fight to reduce the global burden of cardiovascular disease
‡9
1
|
|
919
|
|
|
‡a
effectofelevatedbodymassindexonischemicheartdiseaseriskcausalestimatesfromamendelianrandomisationapproach
‡A
The effect of elevated body mass index on ischemic heart disease risk: causal estimates from a Mendelian randomisation approach
‡9
1
|
|
919
|
|
|
‡a
dynamicandmultifacetednatureofcardiovasculardiseaseandusinggenetictestingtoinformclinicalcareaninternationalperspective
‡A
The Dynamic and Multifaceted Nature of Cardiovascular Disease and Using Genetic Testing to Inform Clinical Care: An International Perspective
‡9
1
|
|
919
|
|
|
‡a
abcg58cholesteroltransporterandmyocardialinfarctionversusgallstonedisease
‡A
The ABCG5/8 cholesterol transporter and myocardial infarction versus gallstone disease.
‡9
1
|
|
919
|
|
|
‡a
systematicallymissingconfoundersinindividualparticipantdatametaanalysisofobservationalcohortstudies
‡A
Systematically missing confounders in individual participant data meta-analysis of observational cohort studies
‡9
1
|
|
919
|
|
|
‡a
surfactantproteinb121ins2heterozygosityreducedpulmonaryfunctionandcopdinsmokers
‡A
Surfactant Protein-B 121ins2 Heterozygosity, Reduced Pulmonary Function And COPD In Smokers
‡9
1
|
|
919
|
|
|
‡a
surfactantproteinb121ins2heterozygosityreducedpulmonaryfunctionandchronicobstructivepulmonarydiseaseinsmokers
‡A
Surfactant Protein-B 121ins2 Heterozygosity, Reduced Pulmonary Function, and Chronic Obstructive Pulmonary Disease in Smokers
‡9
1
|
|
919
|
|
|
‡a
subsetsofsnpsdefineraregenotypeclassesthatpredictischemicheartdisease
‡A
Subsets of SNPs define rare genotype classes that predict ischemic heart disease
‡9
1
|
|
919
|
|
|
‡a
subgroupsathighriskforischaemicheartdiseaseidentificationandvalidationin67000individualsfromthegeneralpopulation
‡A
Subgroups at high risk for ischaemic heart disease:identification and validation in 67 000 individuals from the general population
‡9
1
|
|
919
|
|
|
‡a
strobemrguidelinesforstrengtheningthereportingofmendelianrandomizationstudies
‡A
STROBE-MR: Guidelines for strengthening the reporting of Mendelian randomization studies
‡9
1
|
|
919
|
|
|
‡a
steroltransporteradenosinetriphosphatebindingcassettetransporterg8gallstonesandbiliarycancerin62000individualsfromthegeneralpopulation
‡A
Sterol transporter adenosine triphosphate-binding cassette transporter G8, gallstones, and biliary cancer in 62,000 individuals from the general population
‡9
1
|
|
919
|
|
|
‡a
splicesitemutationsinmismatchrepairgenesandriskofcancerinthegeneralpopulation
‡A
Splice site mutations in mismatch repair genes and risk of cancer in the general population.
‡9
1
|
|
919
|
|
|
‡a
6casecontrolstudiesfromtheosterbrostudythecopenhagencityheartstudyangiotensinogenmutationsandriskofmyocardialandcerebralischemia
‡A
[Six case-control studies from the Osterbro-study (The Copenhagen City Heart Study). Angiotensinogen mutations and risk of myocardial and cerebral ischemia]
‡9
1
|
|
919
|
|
|
‡a
6casecontrolstudiesfromtheosterbrostudy
‡A
[Six case-control studies from the Osterbro-study
‡9
1
|
|
919
|
|
|
‡a
singlenucleotidepolymorphisminthelowdensitylipoproteinreceptorisassociatedwithathreefoldriskofstrokeacasecontrolandprospectivestudy
‡A
Single nucleotide polymorphism in the low-density lipoprotein receptor is associated with a threefold risk of stroke. A case-control and prospective study
‡9
1
|
|
919
|
|
|
‡a
shorttelomerelengthmyocardialinfarctionischemicheartdiseaseandearlydeath
‡A
Short telomere length, myocardial infarction, ischemic heart disease, and early death
‡9
1
|
|
919
|
|
|
‡a
shorttelomerelengthcancersurvivalandcancerriskin47102individuals
‡A
Short telomere length, cancer survival, and cancer risk in 47102 individuals
‡9
1
|
|
919
|
|
|
‡a
sexhormonesandischemicstrokeaprospectivecohortstudyandmetaanalyses
‡A
Sex Hormones and Ischemic Stroke: A Prospective Cohort Study and Meta-Analyses
‡9
1
|
|
919
|
|
|
‡a
serumsolublecd163predictsriskoftype2diabetesinthegeneralpopulation
‡A
Serum Soluble CD163 Predicts Risk of Type 2 Diabetes in the General Population
‡9
1
|
|
919
|
|
|
‡a
effectofapoeεgenotypeonlipoprotein
‡A
Effect of APOE ε Genotype on Lipoprotein
‡9
1
|
|
919
|
|
|
‡a
effectofapoeεgenotypeonlipoproteinaandtheassociatedriskofmyocardialinfarctionandaorticvalvestenosis
‡A
Effect of APOE ε Genotype on Lipoprotein(a) and the Associated Risk of Myocardial Infarction and Aortic Valve Stenosis
‡9
1
|
|
919
|
|
|
‡a
effectofgenderonphenotypicexpressionofthes447xmutationinlplthecopenhagencityheartstudy
‡A
Effect of gender on phenotypic expression of the S447X mutation in LPL: the Copenhagen City Heart Study
‡9
1
|
|
919
|
|
|
‡a
elevatedbodymassindexasacausalriskfactorforsymptomaticgallstonediseaseamendelianrandomizationstudy
‡A
Elevated body mass index as a causal risk factor for symptomatic gallstone disease: a Mendelian randomization study
‡9
1
|
|
919
|
|
|
‡a
elevatedfibrinogenlevelsareassociatedwithriskofpulmonaryembolismbutnotwithdeepvenousthrombosis
‡A
Elevated Fibrinogen Levels Are Associated with Risk of Pulmonary Embolism, but Not with Deep Venous Thrombosis
‡9
1
|
|
919
|
|
|
‡a
screeningof3novelcandidategenesinarrhythmogenicrightventricularcardiomyopathy
‡A
Screening of three novel candidate genes in arrhythmogenic right ventricular cardiomyopathy
‡9
1
|
|
919
|
|
|
‡a
scavengerreceptorai2truncationlungfunctionandcopdin48700individuals
‡A
Scavenger receptor AI/II truncation, lung function and COPD in 48,700 individuals
‡9
1
|
|
919
|
|
|
‡a
scarb1genevariantsareassociatedwiththephenotypeofcombinedhighhighdensitylipoproteincholesterolandhighlipoproteina
‡A
SCARB1 Gene Variants Are Associated With the Phenotype of Combined High High-Density Lipoprotein Cholesterol and High Lipoprotein (a).
‡9
1
|
|
919
|
|
|
‡a
scarb1genevariantsareassociatedwiththephenotypeofcombinedhighhighdensitylipoproteincholesterolandhighlipoprotein
‡A
SCARB1 Gene Variants Are Associated With the Phenotype of Combined High High-Density Lipoprotein Cholesterol and High Lipoprotein
‡9
1
|
|
919
|
|
|
‡a
s1pdihydros1pandc241ceramidelevelsinthehdlcontainingfractionofseruminverselycorrelatewithoccurrenceofischemicheartdisease
‡A
S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease
‡9
1
|
|
919
|
|
|
‡a
elevatedlipoproteinaandriskofaorticvalvestenosisinthegeneralpopulation
‡A
Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population.
‡9
1
|
|
919
|
|
|
‡a
rs641738ctnearmboat7isassociatedwithliverfataltandfibrosisinnafldametaanalysis
‡A
rs641738C>T near MBOAT7 is associated with liver fat, ALT, and fibrosis in NAFLD: a meta-analysis
‡9
1
|
|
919
|
|
|
‡a
elevatedremnantcholesterolcausesbothlowgradeinflammationandischemicheartdiseasewhereaselevatedlowdensitylipoproteincholesterolcausesischemicheartdiseasewithoutinflammation
‡A
Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation
‡9
1
|
|
919
|
|
|
‡a
riskofischemicheartandischemiccerebrovasculardiseaseisnotincreasedinszand11478a Alpha 1antitrypsincarriersofthecopenhagencityheartstudy
‡A
Risk of ischemic heart and ischemic cerebrovascular disease is not increased in S, Z, and 11478A Alpha 1-antitrypsin carriers of the Copenhagen City Heart Study
‡9
1
|
|
919
|
|
|
‡a
elevatedtransferrinsaturationandriskofdiabetes3populationbasedstudies
‡A
Elevated transferrin saturation and risk of diabetes: three population-based studies
‡9
1
|
|
919
|
|
|
‡a
riskofcancerbyatmmissensemutationsinthegeneralpopulation
‡A
Risk of cancer by ATM missense mutations in the general population.
‡9
1
|
|
919
|
|
|
‡a
epigeneticregulationofassociateswithmyocardialinfarctionandplateletfunction
‡A
Epigenetic Regulation of Associates With Myocardial Infarction and Platelet Function
‡9
1
|
|
919
|
|
|
‡a
responsetotheletterresponsetouseofbiomarkerstoidentifynewdrugtargetsandtopredictriskofcardiometabolicoutcomesbyabasiaetal
‡A
Response to the Letter: Response to "Use of biomarkers to identify new drug targets and to predict risk of cardiometabolic outcomes" by Abasi A., et al.
‡9
1
|
|
919
|
|
|
‡a
estrogenreceptorαpolymorphismandriskofcardiovasculardiseasecancerandhipfracture
‡A
Estrogen Receptor α Polymorphism and Risk of Cardiovascular Disease, Cancer, and Hip Fracture
‡9
1
|
|
919
|
|
|
‡a
responsetoliverfatcontentnonalcoholicfattyliverdiseaseandischaemicheartdisease
‡A
Response to: liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease
‡9
1
|
|
919
|
|
|
‡a
responsetoletterregardingarticlevisibleagerelatedsignsandriskofischemicheartdiseaseinthegeneralpopulationaprospectivecohortstudy
‡A
Response to letter regarding article, "visible age-related signs and risk of ischemic heart disease in the general population: a prospective cohort study".
‡9
1
|
|
919
|
|
|
‡a
reportofthe33rdannualconferenceoftheeuropeanlipoproteinclubtutzing69september
‡A
Report of the 33rd annual conference of the European Lipoprotein Club, Tutzing, 6-9 September 2010.
‡9
1
|
|
919
|
|
|
‡a
replytolettersregardingarticleelevatedremnantcholesterolcausesbothlowgradeinflammationandischemicheartdiseasewhereaselevatedlowdensitylipoproteincholesterolcausesischemicheartdiseasewithoutinflammation
‡A
Reply to Letters Regarding Article, “Elevated Remnant Cholesterol Causes Both Low-Grade Inflammation and Ischemic Heart Disease, Whereas Elevated Low-Density Lipoprotein Cholesterol Causes Ischemic Heart Disease Without Inflammation”
‡9
1
|
|
919
|
|
|
‡a
remnantcholesterollowdensitylipoproteincholesterolandbloodpressureasmediatorsfromobesitytoischemicheartdisease
‡A
Remnant cholesterol, low-density lipoprotein cholesterol, and blood pressure as mediators from obesity to ischemic heart disease.
‡9
1
|
|
919
|
|
|
‡a
remnantcholesterolasacausalriskfactorforischemicheartdisease
‡A
Remnant cholesterol as a causal risk factor for ischemic heart disease
‡9
1
|
|
919
|
|
|
‡a
relationshipbetweengeneticvariationatppp1r3bandliverglycogenandtriglyceridelevels
‡A
Relationship between Genetic Variation at PPP1R3B and Liver Glycogen and Triglyceride Levels
‡9
1
|
|
919
|
|
|
‡a
rarevariantinscavengerreceptorbiraiseshdlcholesterolandincreasesriskofcoronaryheartdisease
‡A
Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease
‡9
1
|
|
919
|
|
|
‡a
prothrombinandriskofvenousthromboembolismischemicheartdiseaseandischemiccerebrovasculardiseaseinthegeneralpopulation
‡A
Prothrombin and risk of venous thromboembolism, ischemic heart disease and ischemic cerebrovascular disease in the general population
‡9
1
|
|
919
|
|
|
‡a
promotorpolymorphismsinleukotrienec4synthaseandriskofischemiccerebrovasculardisease
‡A
Promotor polymorphisms in leukotriene C4 synthase and risk of ischemic cerebrovascular disease
‡9
1
|
|
919
|
|
|
‡a
promoterhaplotypeofanewabca1mutantinfluencesexpressionoffamilialhypo Alpha lipoproteinemia
‡A
Promoter haplotype of a new ABCA1 mutant influences expression of familial hypo Alpha lipoproteinemia
‡9
1
|
|
919
|
|
|
‡a
prevalenceofhemochromatosisassociatedmutationsinthehemochromatosisgeneinthedanishpopulation
‡A
Prevalence of hemochromatosis-associated mutations in the hemochromatosis gene in the Danish population
‡9
1
|
|
919
|
|
|
‡a
europeanlipoproteinclubreportofthe31stelcannualconferencetutzing811september
‡A
European Lipoprotein Club: report of the 31st ELC Annual Conference, Tutzing, 8-11 September 2008.
‡9
1
|
|
919
|
|
|
‡a
europeanlipoproteinclubreportofthe34thelcannualconferencetutzing58september
‡A
European Lipoprotein Club: Report of the 34th ELC annual conference, Tutzing, 5-8 September 2011.
‡9
1
|
|
919
|
|
|
‡a
europeanlipoproteinclubreportofthe35thelcannualconferencetutzing1013september
‡A
European lipoprotein club: report of the 35th ELC annual conference (Tutzing, 10th-13th September 2012).
‡9
1
|
|
919
|
|
|
‡a
exomewideassociationstudyidentifiesatm6sf2variantthatconferssusceptibilitytononalcoholicfattyliverdisease
‡A
Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease
‡9
1
|
|
919
|
|
|
‡a
postprandialhypertriglyceridaemiarevisitedintheeraofnonfastinglipidprofilesexecutivesummaryofa2019expertpanelstatement
‡A
Postprandial Hypertriglyceridaemia Revisited in the Era of Non-fasting Lipid Profiles: Executive Summary of a 2019 Expert Panel Statement
‡9
1
|
|
919
|
|
|
‡a
postprandialhypertriglyceridaemiarevisitedintheeraofnonfastinglipidprofiletestinga2019expertpanelstatementnarrativereview
‡A
Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Narrative Review
‡9
1
|
|
919
|
|
|
‡a
postprandialhypertriglyceridaemiarevisitedintheeraofnonfastinglipidprofiletestinga2019expertpanelstatementmaintext
‡A
Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Main Text
‡9
1
|
|
919
|
|
|
‡a
populationbasedresequencingofapoa1in10330individualsspectrumofgeneticvariationphenotypeandcomparisonwithextremephenotypeapproach
‡A
Population-based resequencing of APOA1 in 10,330 individuals: spectrum of genetic variation, phenotype, and comparison with extreme phenotype approach
‡9
1
|
|
919
|
|
|
‡a
populationbasedresequencingofangptl4uncoversvariationsthatreducetriglyceridesandincreasehdl
‡A
Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL.
‡9
1
|
|
919
|
|
|
‡a
polymorphismsinapolipoproteinbandriskofischemicstroke
‡A
Polymorphisms in apolipoprotein B and risk of ischemic stroke
‡9
1
|
|
919
|
|
|
‡a
extremebilirubinlevelsasacausalriskfactorforsymptomaticgallstonedisease
‡A
Extreme bilirubin levels as a causal risk factor for symptomatic gallstone disease
‡9
1
|
|
919
|
|
|
‡a
extremeconcentrationsofendogenoussexhormonesischemicheartdiseaseanddeathinwomen
‡A
Extreme concentrations of endogenous sex hormones, ischemic heart disease, and death in women
‡9
1
|
|
919
|
|
|
‡a
polymorphisminapobassociatedwithincreasedlowdensitylipoproteinlevelsinbothgendersinthegeneralpopulation
‡A
Polymorphism in APOB associated with increased low-density lipoprotein levels in both genders in the general population
‡9
1
|
|
919
|
|
|
‡a
extremelipoprotein
‡A
Extreme lipoprotein
‡9
1
|
|
919
|
|
|
‡a
plateletglycoproteiniibiiiapla2pla2homozygosityassociatedwithriskofischemiccardiovasculardiseaseandmyocardialinfarctioninyoungmenthecopenhagencityheartstudy
‡A
Platelet glycoprotein IIb/IIIa Pl(A2)/Pl(A2) homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men: the Copenhagen City Heart Study
‡9
1
|
|
919
|
|
|
‡a
extremelipoproteinalevelsandimprovedcardiovascularriskprediction
‡A
Extreme lipoprotein(a) levels and improved cardiovascular risk prediction
‡9
1
|
|
919
|
|
|
‡a
plateletglycoproteiniibiiiapl
‡A
Platelet glycoprotein IIb/IIIa Pl
‡9
1
|
|
919
|
|
|
‡a
extremelipoproteinalevelsandriskofmyocardialinfarctioninthegeneralpopulationthecopenhagencityheartstudy
‡A
Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study
‡9
1
|
|
919
|
|
|
‡a
plasmaykl40andtotalanddiseasespecificmortalityinthegeneralpopulation
‡A
Plasma YKL-40 and total and disease-specific mortality in the general population
‡9
1
|
|
919
|
|
|
‡a
plasmalevelsofapolipoproteineapoegenotypeandallcauseandcausespecificmortalityin105949individualsfromawhitegeneralpopulationcohort
‡A
Plasma levels of apolipoprotein E, APOE genotype, and all-cause and cause-specific mortality in 105 949 individuals from a white general population cohort
‡9
1
|
|
919
|
|
|
‡a
plasmalevelsofapolipoproteineandriskofischemicheartdiseaseinthegeneralpopulation
‡A
Plasma levels of apolipoprotein E and risk of ischemic heart disease in the general population
‡9
1
|
|
919
|
|
|
‡a
plasmalevelsofapolipoproteineandriskofdementiainthegeneralpopulation
‡A
Plasma levels of apolipoprotein E and risk of dementia in the general population
‡9
1
|
|
919
|
|
|
‡a
plasmalevelsof27hydroxycholesterolinhumansandmicewithmonogenicdisturbancesofhighdensitylipoproteinmetabolism
‡A
Plasma levels of 27-hydroxycholesterol in humans and mice with monogenic disturbances of high density lipoprotein metabolism
‡9
1
|
|
919
|
|
|
‡a
plasmafibrinogenlevelandtheriskofmajorcardiovasculardiseasesandnonvascularmortalityanindividualparticipantmetaanalysis
‡A
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.
‡9
1
|
|
919
|
|
|
‡a
plasmaapolipoproteinelevelsandriskofdementiaamendelianrandomizationstudyof106562individuals
‡A
Plasma apolipoprotein E levels and risk of dementia: A Mendelian randomization study of 106,562 individuals.
‡9
1
|
|
919
|
|
|
‡a
plakophilin2100419ctandriskofheartfailureandarrhythmiasinthegeneralpopulation
‡A
Plakophilin-2 c.419C>T and risk of heart failure and arrhythmias in the general population
‡9
1
|
|
919
|
|
|
‡a
phenotypeofheterozygotesforlowdensitylipoproteinreceptormutationsidentifiedindifferentbackgroundpopulations
‡A
Phenotype of heterozygotes for low-density lipoprotein receptor mutations identified in different background populations
‡9
1
|
|
919
|
|
|
‡a
pentanucleotiderepeatpolymorphismlipoproteinalevelsandriskofischemicheartdisease
‡A
Pentanucleotide repeat polymorphism, lipoprotein(a) levels, and risk of ischemic heart disease
‡9
1
|
|
919
|
|
|
‡a
penetranceofnod2card15geneticvariantsinthegeneralpopulation
‡A
Penetrance of NOD2/CARD15 genetic variants in the general population
‡9
1
|
|
919
|
|
|
‡a
pcsk9r46llowdensitylipoproteincholesterollevelsandriskofischemicheartdisease3independentstudiesandmetaanalyses
‡A
PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses
‡9
1
|
|
919
|
|
|
‡a
pcsk9r46llossoffunctionmutationreduceslipoproteinaldlcholesterolandriskofaorticvalvestenosis
‡A
PCSK9 R46L Loss-of-Function Mutation Reduces Lipoprotein(a), LDL Cholesterol, and Risk of Aortic Valve Stenosis.
‡9
1
|
|
919
|
|
|
‡a
overviewofthecurrentstatusoffamilialhypercholesterolaemiacareinover60countriestheeasfamilialhypercholesterolaemiastudiescollaborationfhsc
‡A
Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
‡9
1
|
|
919
|
|
|
‡a
overviewofthecurrentstatusoffamilialhypercholesterolaemiacareinover60countriestheeasfamilialhypercholesterolaemiastudiescollaboration
‡A
Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration
‡9
1
|
|
919
|
|
|
‡a
novelgenesinldlmetabolismacomprehensiveoverview
‡A
Novel genes in LDL metabolism--a comprehensive overview
‡9
1
|
|
919
|
|
|
‡a
noseandbloodpressure
‡A
Nose and blood pressure
‡9
1
|
|
919
|
|
|
‡a
nonfastingtriglyceridescholesterolandischemicstrokeinthegeneralpopulation
‡A
Nonfasting triglycerides, cholesterol, and ischemic stroke in the general population
‡9
1
|
|
919
|
|
|
‡a
nonfastingtriglyceridesandriskofmyocardialinfarctionischemicheartdiseaseanddeathinmenandwomen
‡A
Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women
‡9
1
|
|
919
|
|
|
‡a
nonfastingtriglyceridesandriskofischemicstrokesecondarypublication
‡A
[Nonfasting triglycerides and risk of ischemic stroke--secondary publication].
‡9
1
|
|
919
|
|
|
‡a
nonfastingtriglyceridesandriskofischemicstrokeinthegeneralpopulation
‡A
Nonfasting triglycerides and risk of ischemic stroke in the general population
‡9
1
|
|
919
|
|
|
‡a
nonfastingglucoseischemicheartdiseaseandmyocardialinfarctionamendelianrandomizationstudy
‡A
Nonfasting glucose, ischemic heart disease, and myocardial infarction: a Mendelian randomization study
‡9
1
|
|
919
|
|
|
‡a
nonfastingtriglyceridesandriskofformyocardialinfarctionanddeathamongwomenandmen
‡A
Non-fasting triglycerides and risk of for myocardial infarction and death among women and men
‡9
1
|
|
919
|
|
|
‡a
noassociationofbreastcancerriskwithintegrinbeta3itgb3leu33progenotype
‡A
No association of breast cancer risk with integrin beta3 (ITGB3) Leu33Pro genotype
‡9
1
|
|
919
|
|
|
‡a
nicotinicacetylcholinereceptorpolymorphismsmokingbehaviorandtobaccorelatedcancerandlungandcardiovasculardiseasesacohortstudy
‡A
Nicotinic acetylcholine receptor polymorphism, smoking behavior, and tobacco-related cancer and lung and cardiovascular diseases: a cohort study
‡9
1
|
|
919
|
|
|
‡a
naturallyoccurringvariantsinlrp1lowdensitylipoproteinreceptorrelatedprotein1affecthdlhighdensitylipoproteinmetabolismthroughabca1atpbindingcassettea1andsrb1scavengerreceptorclassbtype1inhumans
‡A
Naturally Occurring Variants in LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1) Affect HDL (High-Density Lipoprotein) Metabolism Through ABCA1 (ATP-Binding Cassette A1) and SR-B1 (Scavenger Receptor Class B Type 1) in Humans.
‡9
1
|
|
919
|
|
|
‡a
naturallyoccurringvariantsinlrp1
‡A
Naturally Occurring Variants in LRP1
‡9
1
|
|
919
|
|
|
‡a
nanogenmicroelectronicchipforlargescalegenotyping
‡A
Nanogen microelectronic chip for large-scale genotyping.
‡9
1
|
|
919
|
|
|
‡a
mutationsindanishpatientswithlongqtsyndromeandtheidentificationofalargefounderfamilywithpf29linkcnh2
‡A
Mutations in Danish patients with long QT syndrome and the identification of a large founder family with p.F29L in KCNH2.
‡9
1
|
|
919
|
|
|
‡a
mutationscausativeoffamilialhypercholesterolaemiascreeningof98098individualsfromthecopenhagengeneralpopulationstudyestimatedaprevalenceof1in217
‡A
Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217
‡9
1
|
|
919
|
|
|
‡a
mutationinapolipoproteinbassociatedwithhypobetalipoproteinemiadespitedecreasedbindingtothelowdensitylipoproteinreceptor
‡A
Mutation in apolipoprotein B associated with hypobetalipoproteinemia despite decreased binding to the low density lipoprotein receptor
‡9
1
|
|
919
|
|
|
‡a
mutationinabca1predictedriskofischemicheartdiseaseinthecopenhagencityheartstudypopulation
‡A
Mutation in ABCA1 predicted risk of ischemic heart disease in the Copenhagen City Heart Study Population
‡9
1
|
|
919
|
|
|
‡a
morbidityandmortalityinpersonswithmannosebindinglectindeficiencytheosterbrostudy
‡A
Morbidity and mortality in persons with mannose-binding lectin deficiency. The Osterbro study
‡9
1
|
|
919
|
|
|
‡a
modificationstothepatientruleinductionmethodthatutilizenonadditivecombinationsofgeneticandenvironmentaleffectstodefinepartitionsthatpredictischemicheartdisease
‡A
Modifications to the Patient Rule-Induction Method that utilize non-additive combinations of genetic and environmental effects to define partitions that predict ischemic heart disease
‡9
1
|
|
919
|
|
|
‡a
mitochondrialhaplogroupsischemiccardiovasculardiseaseotherdiseasesmortalityandlongevityinthegeneralpopulation
‡A
Mitochondrial haplogroups: ischemic cardiovascular disease, other diseases, mortality, and longevity in the general population
‡9
1
|
|
919
|
|
|
‡a
missensevariantsinplakophilin2inarrhythmogenicrightventricularcardiomyopathypatientsdiseasecausingorinnocentbystanders
‡A
Missense Variants in Plakophilin-2 in Arrhythmogenic Right Ventricular Cardiomyopathy Patients – Disease-Causing or Innocent Bystanders?
‡9
1
|
|
919
|
|
|
‡a
missensepolymorphismsinbrca1andbrca2andriskofbreastandovariancancer
‡A
Missense polymorphisms in BRCA1 and BRCA2 and risk of breast and ovarian cancer.
‡9
1
|
|
919
|
|
|
‡a
methylenetetrahydrofolatereductasepolymorphismc677thyperhomocysteinemiaandriskofischemiccardiovasculardiseaseandvenousthromboembolismprospectiveandcasecontrolstudiesfromthecopenhagencityheartstudy
‡A
Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism: prospective and case-control studies from the Copenhagen City Heart Study
‡9
1
|
|
919
|
|
|
‡a
medullarythyroidcancerrettestingofanarchivalmaterial
‡A
Medullary thyroid cancer: RET testing of an archival material
‡9
1
|
|
919
|
|
|
‡a
lownonfastingtriglyceridesandreducedallcausemortalityamendelianrandomizationstudy
‡A
Low nonfasting triglycerides and reduced all-cause mortality: a mendelian randomization study
‡9
1
|
|
919
|
|
|
‡a
lowldlcholesterolpcsk9andhmgcrgeneticvariationandriskofalzheimersdiseaseandparkinsonsdiseasemendelianrandomisationstudy
‡A
Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer's disease and Parkinson's disease: Mendelian randomisation study
‡9
1
|
|
919
|
|
|
‡a
lowldlcholesterolbypcsk9variationreducescardiovascularmortality
‡A
Low LDL Cholesterol by PCSK9 Variation Reduces Cardiovascular Mortality
‡9
1
|
|
919
|
|
|
‡a
lowdensitylipoproteincholesterolandtheriskofcanceramendelianrandomizationstudy
‡A
Low-density lipoprotein cholesterol and the risk of cancer: a mendelian randomization study.
‡9
1
|
|
919
|
|
|
‡a
lowdensitylipoproteincholesterolandriskofgallstonediseaseamendelianrandomizationstudyandmetaanalyses
‡A
Low-density lipoprotein cholesterol and risk of gallstone disease: a Mendelian randomization study and meta-analyses
‡9
1
|
|
919
|
|
|
‡a
lossoffunctionmutationsinapoc3andriskofischemicvasculardisease
‡A
Loss-of-function mutations in APOC3 and risk of ischemic vascular disease
‡9
1
|
|
919
|
|
|
‡a
lossoffunctionmutationinabca1andriskofalzheimersdiseaseandcerebrovasculardisease
‡A
Loss-of-function mutation in ABCA1 and risk of Alzheimer's disease and cerebrovascular disease
‡9
1
|
|
919
|
|
|
‡a
liverfatcontentnonalcoholicfattyliverdiseaseandischaemicheartdiseasemendelianrandomizationandmetaanalysisof279013individuals
‡A
Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals
‡9
1
|
|
919
|
|
|
‡a
lipoproteindistributionandserumconcentrationsof7αhydroxy4cholesten31andbileacidseffectsofmonogenicdisturbancesinhighdensitylipoproteinmetabolism
‡A
Lipoprotein distribution and serum concentrations of 7α-hydroxy-4-cholesten-3-one and bile acids: effects of monogenic disturbances in high-density lipoprotein metabolism
‡9
1
|
|
919
|
|
|
‡a
lipoproteinaasacardiovascularriskfactorcurrentstatus
‡A
Lipoprotein(a) as a cardiovascular risk factor: current status
‡9
1
|
|
919
|
|
|
‡a
lipoproteinaandriskofmyocardialinfarctiongeneticepidemiologicevidenceofcausality
‡A
Lipoprotein(a) and risk of myocardial infarction--genetic epidemiologic evidence of causality
‡9
1
|
|
919
|
|
|
‡a
lipoproteinaandfamilialhypercholesterolaemiaauthorsreply
‡A
Lipoprotein(a) and familial hypercholesterolaemia - Authors' reply.
‡9
1
|
|
919
|
|
|
‡a
levelsofapolipoprotein1000arenotassociatedwiththeriskofcoronaryheartdiseasein2independentcasecontrolstudies
‡A
Levels of apolipoprotein M are not associated with the risk of coronary heart disease in two independent case-control studies
‡9
1
|
|
919
|
|
|
‡a
leukotrienec4synthaseandischemiccardiovasculardiseaseandobstructivepulmonarydiseasein13000individuals
‡A
Leukotriene C4 synthase and ischemic cardiovascular disease and obstructive pulmonary disease in 13,000 individuals
‡9
1
|
|
919
|
|
|
‡a
lcathdlcholesterolandischemiccardiovasculardiseaseamendelianrandomizationstudyofhdlcholesterolin54500individuals
‡A
LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals
‡9
1
|
|
919
|
|
|
‡a
integrinbeta3leu33propolymorphismandriskofhipfracture25yearsfollowupof9233adultsfromthegeneralpopulation
‡A
Integrin beta3 Leu33Pro polymorphism and risk of hip fracture: 25 years follow-up of 9233 adults from the general population
‡9
1
|
|
919
|
|
|
‡a
integrinbeta3leu33prohomozygosityandriskofcancer
‡A
Integrin beta3 Leu33Pro homozygosity and risk of cancer
‡9
1
|
|
919
|
|
|
‡a
inhibitionofcholesterylestertransferproteinpreserveshighdensitylipoproteincholesterolandimprovessurvivalinsepsis
‡A
Inhibition of Cholesteryl Ester Transfer Protein Preserves High-Density Lipoprotein Cholesterol and Improves Survival in Sepsis
‡9
1
|
|
919
|
|
|
‡a
influenceofthefactor5leidenmutationoninfectiousdiseasesusceptibilityandoutcomeapopulationbasedstudy
‡A
Influence of the factor V Leiden mutation on infectious disease susceptibility and outcome: a population-based study
‡9
1
|
|
919
|
|
|
‡a
influenceoffactor5leidenonsusceptibilitytoandoutcomefromcriticalillnessageneticassociationstudy
‡A
Influence of Factor V Leiden on susceptibility to and outcome from critical illness: a genetic association study
‡9
1
|
|
919
|
|
|
‡a
increasedriskofovariancancerinintegrinbeta3leu33prohomozygotes
‡A
Increased risk of ovarian cancer in integrin beta3 Leu33Pro homozygotes
‡9
1
|
|
919
|
|
|
‡a
increasedriskofbreastcancerassociatedwithchek21100delc
‡A
Increased risk of breast cancer associated with CHEK2*1100delC
‡9
1
|
|
919
|
|
|
‡a
increasedbaseline100reactiveproteinconcentrationsareassociatedwithincreasedriskofinfectionsresultsfrom2largedanishpopulationcohorts
‡A
Increased Baseline C-Reactive Protein Concentrations Are Associated with Increased Risk of Infections: Results from 2 Large Danish Population Cohorts
‡9
1
|
|
919
|
|
|
‡a
improvingpredictionofischemiccardiovasculardiseaseinthegeneralpopulationusingapolipoproteinbthecopenhagencityheartstudy
‡A
Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B: the Copenhagen City Heart Study
‡9
1
|
|
919
|
|
|
‡a
impactofldlcholesterolonmicrovascularversusmacrovasculardiseaseamendelianrandomizationstudy
‡A
Impact of LDL Cholesterol on Microvascular Versus Macrovascular Disease: A Mendelian Randomization Study
‡9
1
|
|
919
|
|
|
‡a
impactofglucoseonriskofdementiamendelianrandomisationstudiesin115875individuals
‡A
Impact of glucose on risk of dementia: Mendelian randomisation studies in 115,875 individuals
‡9
1
|
|
919
|
|
|
‡a
impactofglucoselevelonmicroandmacrovasculardiseaseinthegeneralpopulationamendelianrandomizationstudy
‡A
Impact of Glucose Level on Micro- and Macrovascular Disease in the General Population: A Mendelian Randomization Study
‡9
1
|
|
919
|
|
|
‡a
impactofcardiovascularriskfactorsandgeneticson10yearabsoluteriskofdementiariskchartsfortargetedprevention
‡A
Impact of cardiovascular risk factors and genetics on 10-year absolute risk of dementia: risk charts for targeted prevention
‡9
1
|
|
943
|
|
|
‡a
201x
‡A
2013
‡9
4
|
|
943
|
|
|
‡a
200x
‡A
2008
‡9
1
|
|
946
|
|
|
‡a
a
‡9
1
|
|
947
|
|
|
‡a
DK
‡9
1
|
|
996
|
|
|
‡2
BIBSYS|98008327
|
|
996
|
|
|
‡2
LC|no2020008055
|
|
996
|
|
|
‡2
DBC|87097968533333
|
|
996
|
|
|
‡2
ISNI|0000000026173103
|
|
996
|
|
|
‡2
ISNI|000000003828314X
|
|
996
|
|
|
‡2
LC|nr2003011979
|
|
996
|
|
|
‡2
DNB|1063009863
|
|
996
|
|
|
‡2
DNB|126367019
|
|
996
|
|
|
‡2
DBC|87097919405125
|
|
996
|
|
|
‡2
NKC|uk2009539324
|
|
996
|
|
|
‡2
NUKAT|n 95402452
|
|
996
|
|
|
‡2
BIBSYS|7040019
|
|
996
|
|
|
‡2
DBC|87097968719968
|
|
996
|
|
|
‡2
DBC|87097968390265
|
|
996
|
|
|
‡2
BIBSYS|90084255
|
|
996
|
|
|
‡2
DBC|870979135581771
|
|
996
|
|
|
‡2
DBC|87097919508218
|
|
996
|
|
|
‡2
BNF|15794632
|
|
996
|
|
|
‡2
RERO|A020235972
|
|
996
|
|
|
‡2
BIBSYS|6067782
|
|
996
|
|
|
‡2
DBC|87097939405008
|
|
996
|
|
|
‡2
BIBSYS|1602157057258
|
|
996
|
|
|
‡2
LC|no2021148852
|
|
996
|
|
|
‡2
DNB|1014333040
|
|
996
|
|
|
‡2
DNB|1244345490
|
|
996
|
|
|
‡2
ISNI|0000000423114537
|
|
996
|
|
|
‡2
ISNI|000000051100686X
|
|
996
|
|
|
‡2
DBC|87097968480620
|
|
996
|
|
|
‡2
SELIBR|198438
|
|
996
|
|
|
‡2
ISNI|0000000035017794
|
|
996
|
|
|
‡2
DBC|87097948624367
|
|
996
|
|
|
‡2
BNF|16707026
|
|
996
|
|
|
‡2
SUDOC|144568284
|
|
996
|
|
|
‡2
BIBSYS|9068149
|
|
996
|
|
|
‡2
LC|n 85829844
|
|
996
|
|
|
‡2
DNB|1130897680
|
|
996
|
|
|
‡2
DBC|87097919278018
|
|
996
|
|
|
‡2
BIBSYS|3096268
|
|
996
|
|
|
‡2
LC|no2020080263
|
|
996
|
|
|
‡2
DBC|87097968400821
|
|
996
|
|
|
‡2
BIBSYS|1615358757231
|
|
996
|
|
|
‡2
BNF|12986789
|
|
996
|
|
|
‡2
BIBSYS|90743773
|
|
996
|
|
|
‡2
PLWABN|9814276998005606
|
|
996
|
|
|
‡2
DBC|87097948520316
|
|
996
|
|
|
‡2
DBC|87097938383116
|
|
996
|
|
|
‡2
BIBSYS|7059690
|
|
996
|
|
|
‡2
LC|no2008095006
|
|
996
|
|
|
‡2
DBC|87097968390346
|
|
996
|
|
|
‡2
DBC|87097990912593
|
|
996
|
|
|
‡2
BIBSYS|90831901
|
|
996
|
|
|
‡2
DBC|87097919393348
|
|
996
|
|
|
‡2
DBC|87097968181968
|
|
996
|
|
|
‡2
DNB|1158863004
|
|
996
|
|
|
‡2
DBC|870979137332264
|
|
996
|
|
|
‡2
BIBSYS|4021834
|
|
996
|
|
|
‡2
NUKAT|nx2023999158
|
|
996
|
|
|
‡2
DBC|87097990166700
|
|
996
|
|
|
‡2
DBC|87097968614147
|
|
996
|
|
|
‡2
BIBSYS|98051725
|
|
996
|
|
|
‡2
BIBSYS|5071266
|
|
996
|
|
|
‡2
BIBSYS|2057803
|
|
996
|
|
|
‡2
DNB|1243708891
|
|
996
|
|
|
‡2
BIBSYS|3095515
|
|
996
|
|
|
‡2
DBC|87097968368502
|
|
996
|
|
|
‡2
LC|no2024027545
|
|
996
|
|
|
‡2
ISNI|0000000383661041
|
|
996
|
|
|
‡2
DBC|87097947642884
|
|
996
|
|
|
‡2
CAOONL|ncf10111055
|
|
996
|
|
|
‡2
BNF|18057916
|
|
996
|
|
|
‡2
LC|n 2016058537
|
|
996
|
|
|
‡2
ISNI|000000042881978X
|
|
996
|
|
|
‡2
BIBSYS|3090939
|
|
996
|
|
|
‡2
ISNI|0000000115019458
|
|
996
|
|
|
‡2
LC|n 2001018812
|
|
996
|
|
|
‡2
DBC|87097938999699
|
|
996
|
|
|
‡2
BIBSYS|8079606
|
|
996
|
|
|
‡2
BIBSYS|1634281496101
|
|
996
|
|
|
‡2
DBC|87097992163245
|
|
996
|
|
|
‡2
DNB|128360526
|
|
996
|
|
|
‡2
DBC|87097919259862
|
|
996
|
|
|
‡2
DBC|870979136359495
|
|
996
|
|
|
‡2
ISNI|0000000423446443
|
|
996
|
|
|
‡2
ISNI|000000039443387X
|
|
996
|
|
|
‡2
ISNI|0000000490515365
|
|
996
|
|
|
‡2
DBC|87097968246245
|
|
996
|
|
|
‡2
BIBSYS|90984343
|
|
996
|
|
|
‡2
DNB|142181625
|
|
996
|
|
|
‡2
LC|n 88210426
|
|
996
|
|
|
‡2
DBC|87097969275893
|
|
996
|
|
|
‡2
DBC|87097992102890
|
|
996
|
|
|
‡2
BIBSYS|90725962
|
|
996
|
|
|
‡2
LC|no2019188434
|
|
996
|
|
|
‡2
SELIBR|195506
|
|
996
|
|
|
‡2
LC|n 2008023423
|
|
996
|
|
|
‡2
BIBSYS|4067891
|
|
996
|
|
|
‡2
ISNI|0000000028472609
|
|
996
|
|
|
‡2
ISNI|0000000428895838
|
|
996
|
|
|
‡2
NUKAT|n 2012254627
|
|
996
|
|
|
‡2
BIBSYS|90880919
|
|
996
|
|
|
‡2
DBC|870979138808629
|
|
996
|
|
|
‡2
BIBSYS|15005542
|
|
996
|
|
|
‡2
DBC|87097990912658
|
|
996
|
|
|
‡2
DBC|87097968390311
|
|
996
|
|
|
‡2
LC|no2015158212
|
|
996
|
|
|
‡2
BIBSYS|2108350
|
|
996
|
|
|
‡2
LNB|LNC10-000242611
|
|
996
|
|
|
‡2
ISNI|0000000429160454
|
|
996
|
|
|
‡2
BIBSYS|50870
|
|
996
|
|
|
‡2
DBC|87097969308597
|
|
996
|
|
|
‡2
NTA|071015221
|
|
996
|
|
|
‡2
BIBSYS|13069512
|
|
996
|
|
|
‡2
W2Z|11071129
|
|
996
|
|
|
‡2
DBC|87097969104894
|
|
996
|
|
|
‡2
DNB|1254644849
|
|
996
|
|
|
‡2
BIBSYS|90890451
|
|
996
|
|
|
‡2
LC|nb 99015370
|
|
996
|
|
|
‡2
BNF|17001744
|
|
996
|
|
|
‡2
NTA|141372699
|
|
996
|
|
|
‡2
DBC|87097938830228
|
|
996
|
|
|
‡2
DBC|87097990912569
|
|
996
|
|
|
‡2
DBC|870979135464562
|
|
996
|
|
|
‡2
CAOONL|ncf10862641
|
|
996
|
|
|
‡2
DBC|87097968390273
|
|
996
|
|
|
‡2
DBC|870979134370726
|
|
996
|
|
|
‡2
BIBSYS|90391114
|
|
996
|
|
|
‡2
NII|DA15991033
|
|
996
|
|
|
‡2
SUDOC|277273781
|
|
996
|
|
|
‡2
NUKAT|n 2022006950
|
|
996
|
|
|
‡2
LC|n 84229518
|
|
996
|
|
|
‡2
ISNI|0000000451318916
|
|
996
|
|
|
‡2
DBC|87097968951763
|
|
996
|
|
|
‡2
LC|no2020130242
|
|
996
|
|
|
‡2
BIBSYS|11069034
|
|
996
|
|
|
‡2
DBC|87097969805442
|
|
996
|
|
|
‡2
BIBSYS|29989
|
|
996
|
|
|
‡2
W2Z|1602157057258
|
|
996
|
|
|
‡2
DBC|87097968977878
|
|
996
|
|
|
‡2
UIY|000001578
|
|
996
|
|
|
‡2
DBC|87097969225667
|
|
996
|
|
|
‡2
NKC|xx0174834
|
|
996
|
|
|
‡2
DBC|87097969911919
|
|
996
|
|
|
‡2
DBC|87097990912615
|
|
996
|
|
|
‡2
DBC|87097968697425
|
|
996
|
|
|
‡2
BIBSYS|90184765
|
|
996
|
|
|
‡2
SUDOC|253213819
|
|
996
|
|
|
‡2
BIBSYS|90835547
|
|
996
|
|
|
‡2
DBC|87097962220848
|
|
996
|
|
|
‡2
BIBSYS|90108855
|
|
996
|
|
|
‡2
DBC|87097969023363
|
|
996
|
|
|
‡2
DBC|87097992390268
|
|
996
|
|
|
‡2
DBC|87097968507480
|
|
996
|
|
|
‡2
DBC|87097946350219
|
|
996
|
|
|
‡2
DBC|87097968406706
|
|
996
|
|
|
‡2
DBC|87097948050824
|
|
996
|
|
|
‡2
DBC|87097968390354
|
|
996
|
|
|
‡2
J9U|987007430371305171
|
|
996
|
|
|
‡2
BIBSYS|14045184
|
|
996
|
|
|
‡2
BIBSYS|90949509
|
|
996
|
|
|
‡2
NUKAT|n 2015091191
|
|
996
|
|
|
‡2
BIBSYS|15023648
|
|
996
|
|
|
‡2
LC|nb2007017771
|
|
996
|
|
|
‡2
SUDOC|27668723X
|
|
996
|
|
|
‡2
BIBSYS|2028136
|
|
996
|
|
|
‡2
LC|no 00042955
|
|
996
|
|
|
‡2
W2Z|1615358757231
|
|
996
|
|
|
‡2
BIBSYS|1707990465450
|
|
996
|
|
|
‡2
BIBSYS|12010935
|
|
996
|
|
|
‡2
BIBSYS|53573
|
|
996
|
|
|
‡2
DBC|87097968551749
|
|
996
|
|
|
‡2
ISNI|0000000040738553
|
|
996
|
|
|
‡2
DBC|87097969068847
|
|
996
|
|
|
‡2
DBC|87097968070864
|
|
996
|
|
|
‡2
DBC|87097968558395
|
|
996
|
|
|
‡2
LC|n 95117195
|
|
996
|
|
|
‡2
BIBSYS|90969908
|
|
996
|
|
|
‡2
DNB|1321256329
|
|
996
|
|
|
‡2
DBC|87097968390281
|
|
996
|
|
|
‡2
BIBSYS|9050307
|
|
996
|
|
|
‡2
DBC|87097968545978
|
|
996
|
|
|
‡2
BAV|495_392490
|
|
996
|
|
|
‡2
DBC|87097969897231
|
|
996
|
|
|
‡2
DBC|87097946442725
|
|
996
|
|
|
‡2
BIBSYS|98031415
|
|
996
|
|
|
‡2
DBC|87097969198945
|
|
996
|
|
|
‡2
DBC|87097991329727
|
|
996
|
|
|
‡2
DBC|87097990912542
|
|
996
|
|
|
‡2
DBC|87097948562779
|
|
996
|
|
|
‡2
DBC|87097969326404
|
|
996
|
|
|
‡2
DBC|87097968764416
|
|
996
|
|
|
‡2
ISNI|0000000458279251
|
|
996
|
|
|
‡2
LC|no2008041461
|
|
996
|
|
|
‡2
DNB|1061893413
|
|
996
|
|
|
‡2
BIBSYS|5068990
|
|
996
|
|
|
‡2
PLWABN|9810546618605606
|
|
996
|
|
|
‡2
DBC|87097919224139
|
|
996
|
|
|
‡2
BIBSYS|10042832
|
|
996
|
|
|
‡2
NSK|000649862
|
|
996
|
|
|
‡2
SUDOC|114268061
|
|
996
|
|
|
‡2
CAOONL|ncf11909067
|
|
996
|
|
|
‡2
DNB|1061536076
|
|
996
|
|
|
‡2
W2Z|15023648
|
|
996
|
|
|
‡2
LC|n 79086966
|
|
996
|
|
|
‡2
DBC|87097992182983
|
|
996
|
|
|
‡2
DBC|87097990919679
|
|
996
|
|
|
‡2
BIBSYS|90876454
|
|
996
|
|
|
‡2
DBC|87097938447467
|
|
996
|
|
|
‡2
BIBSYS|11071129
|
|
996
|
|
|
‡2
BIBSYS|90971320
|
|
996
|
|
|
‡2
LC|no2012132868
|
|
996
|
|
|
‡2
DBC|87097968390303
|
|
996
|
|
|
‡2
BIBSYS|1983
|
|
996
|
|
|
‡2
DBC|87097961481028
|
|
996
|
|
|
‡2
J9U|987007323656005171
|
|
996
|
|
|
‡2
ISNI|0000000079339912
|
|
996
|
|
|
‡2
J9U|987007369453505171
|
|
996
|
|
|
‡2
BIBSYS|97022543
|
|
996
|
|
|
‡2
SELIBR|137262
|
|
996
|
|
|
‡2
J9U|987007605507105171
|
|
996
|
|
|
‡2
LC|no2009024866
|
|
996
|
|
|
‡2
DBC|87097969837735
|
|
996
|
|
|
‡2
BIBSYS|9070882
|
|
996
|
|
|
‡2
DBC|87097968390249
|
|
996
|
|
|
‡2
BIBSYS|90199181
|
|
996
|
|
|
‡2
ISNI|0000000508133665
|
|
996
|
|
|
‡2
LC|n 2004010162
|
|
996
|
|
|
‡2
ISNI|0000000041278325
|
|
996
|
|
|
‡2
LC|n 2015189613
|
|
996
|
|
|
‡2
BIBSYS|9034952
|
|
996
|
|
|
‡2
J9U|987007381630505171
|
|
996
|
|
|
‡2
BIBSYS|90166718
|
|
996
|
|
|
‡2
ISNI|0000000488864232
|
|
996
|
|
|
‡2
DNB|132554874X
|
|
996
|
|
|
‡2
ISNI|0000000488704351
|
|
996
|
|
|
‡2
RERO|A003346380
|
|
996
|
|
|
‡2
RERO|A003346381
|
|
996
|
|
|
‡2
DBC|87097945967891
|
|
996
|
|
|
‡2
ISNI|0000000031531788
|
|
996
|
|
|
‡2
DBC|87097919491579
|
|
996
|
|
|
‡2
DBC|87097939402718
|
|
996
|
|
|
‡2
J9U|987007447043405171
|
|
996
|
|
|
‡2
ISNI|0000000486967481
|
|
996
|
|
|
‡2
BIBSYS|90514136
|
|
996
|
|
|
‡2
BIBSYS|90345615
|
|
996
|
|
|
‡2
ISNI|000000003208844X
|
|
996
|
|
|
‡2
BIBSYS|11044039
|
|
996
|
|
|
‡2
LC|nr 00010105
|
|
996
|
|
|
‡2
SUDOC|144873699
|
|
996
|
|
|
‡2
DBC|87097946349318
|
|
996
|
|
|
‡2
BIBSYS|1634281496991
|
|
997
|
|
|
‡a
1952 0 lived 1004 0
‡9
1
|
